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1. Introduction  1 
1. Introduction 
 
Fluorescence spectroscopy and the closely related area of phosphorescence spectroscopy have 
become firmly established and widely employed techniques in analytical chemistry. 
Fluorimetry is now routinely used in the detection, quantitation, identification and 
characterization of structure and function of inorganic and organic compounds, and of 
biological structures and processes. Fluorescence spectroscopy is routinely applied and 
successfully to the monitoring of biospecific reactions like as in immunoassays and 
hybridization assays, and in the study of molecular interactions such as ligand-protein binding 
[1]. 
In most of these assays it is not the intrinsic fluorescence of the analyte that is 
measured. There are many cases where the molecule of interest is non-fluorescent (like 
DNA), or where the intrinsic fluorescence is not adequate for the desired experiment. Intrinsic 
protein fluorescence originates from the aromatic amino acids tryptophan, tyrosine, and 
phenylalanine. Their emission maxima are in the range of 280-350 nm. In the case of proteins 
it is frequently advantageous to label them with chromophores which have longer excitation 
and emission wavelengths than the aromatic amino acids. Then the labeled protein can be 
studied in the presence of unlabeled proteins [1, 2]. 
 
1.1. Long-Wavelength Fluorophores and Labels 
Long-wavelength probes and labels are of current interest for several reasons. The sensitivity 
of fluorescence detection is often limited by the autofluorescence of biological samples like 
cells and tissue. It is well known that this autofluorescence decreases with increasing 
wavelength, and hence the detectability over background increases. Therefore the so-called 
optical window of blood and other biological material (see fig. 1.1) is in the range of 600-900 
nm [2, 3]. 
In addition, light of longer wavelength penetrates tissue more easily due to the inverse 
relationship of the scatter of light to the fourth power of the wavelength (Tyndall) which 
makes longer wavelength excitation more attractive for in-vivo measurements, e.g., sensing 
applications through skin or in whole blood [4]. Besides, damage of biological matter is 
decreased at long-wave excitation. It is also advantageous that inexpensive light sources are 
available for excitation of long-wavelength fluorophores. Diode lasers provide convenient 
monochromatic intense excitation sources and are quite cheap in cost and operation [1, 2]. 
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Figure 1.1. Absorption spectra of skin and blood with an optical window in the range of 
600-750 nm, and absorption and emission spectra of a long-wavelength 
fluorophore. 
 
In the following, the cyanine and the squaraine dyes are introduced as examples for long-
wavelength fluorophores this work deals with. 
 
1.1.1. Cyanine Dyes [5] 
Cyanines are cationic polymethine dyes. They form a group of dyes that combine relatively 
long-wave absorption with comparatively small molecular size, a feature that is desirable for 
labels in order not to disturb the system to be probed. In addition, the color of the cyanine dye 
is fairly predictable from its molecular structure. The chemical structure of cyanine dyes can 
be represented in general form by structure X(-CH=CH)n-CH=Y, where X and Y typically 
are nitrogen containing heterocycles like those shown in table 1.1. One of the two 
substitutents (here X) has to be present in quaternized (cationic) form (A to G in table 1.1). 
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Table 1.1. Typical substituents in cyanine dyes of the general structure X(-CH=CH)n-CH=Y 
X Y 
A 
 
 
 
 
 
A’ 
 
B 
 
 
 
 
B’ 
 
 
C 
 
 
 
 
C’ 
 
 
D 
 
 
 
 
 
D’ 
 
E 
 
 
 
E’ 
 
F 
 
 
 
 
F’ 
 
G 
 
 
 
 
G’ 
 
 
The parameter n in X(-CH=CH)n-CH=Y has the largest effect on the absorption maximum 
(λmax). The number of n typically varies from 0 to 3. It is known that the λmax values of 
cyanines increase almost linearly by 100 nm with n (vinylene shift) [6]. Dyes with n = 0 are 
called monocyanines; if n = 1, 2, or 3, they are called tri-, penta- or heptacyanines, 
respectively [6, 7].  
 While the number for n exerts a massive effect on the absorption maxima, spectral fine-
tuning can only be accomplished by variation of substitutents X and Y (see table 1). 
Symmetrical cyanines (i.e., those where heterocycle X is of the same type as is Y) have been 
N
H3C CH3
CH3
N
H3C CH3
CH3
N
CH3
N
CH3
S
N
CH3
S
N
CH3
N
H3C CH3
CH3
N
H3C CH3
CH3
N
CH3
N
CH3
N
CH3
N
CH3
N 
C H 3 
N
CH3
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Y 
X 
described rather often, and their absorption maxima have been measured [6-8]. The 
absorption wavelength of an unsymmetrical cyanine is usually shorter than the arithmetic 
mean of the wavelength of the corresponding two symmetrical dyes with identical end groups 
[9]. Table 1.2 displays compiled absorption maxima for some selected trimethine dyes. 
 
Table 1.2. Calculated absorption maxima (in nm) of trimethine dyes of type X-CH=CH-
CH=Y, showing that by proper variation of substituents (A–G and A'-G', 
respectively; see table 1.1) the whole longwave part of the visible spectrum can be 
covered. Other substituents (e.g. benzo[c,d]indoles) are known as well. It should 
be mentioned that the absorption maximum and the shape of the absorption band is 
dependent on the solvent. 
 
A 543 
B 547 552 
C 549 551 555 
D 565 567 572 590 
E 525 590 579 595 603 
F 551 578 577 598 597 610 
G 615 630 630 642 651 657 710 
 A’ B’ C’ D’ E’ F’ G’ 
 
Based on the above logic, various functional dyes can be prepared [13]. They contain (a) a 
chromophore of predetermined color, (b) a functional group imparting water solubility, and 
(c) a spacer with a terminal functional group (such as COOH) to enable conjugation to 
biomolecules. 
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1.1.2. Squarylium Dyes 
Squarylium dyes (squaraines) belong to the family of the cyanine dyes. In general, squarylium 
dyes are close in wavelength to the cationic pentacyanine dyes. They differ formally from 
them by substitution of H by O- in the meso position of the chain and symmetrical bridging of 
the neighboring carbon atoms by a carbonyl group (fig. 1.2) [6]. 
 
Figure 1.2. General structure of squarylium dyes (X, Y = heterocyclic end groups; see table 
1.1). 
 
Variation of the heterocyclic end groups X and Y and substitution of the oxygen e.g. by a 
dicyanomethylene group or by sulfur makes a large variety of absorption wavelengths 
accessible. Due to their electronic symmetry, squaraines exhibit a sharp absorption with high 
extinction coefficients in the red and near IR region (600-750 nm). The photostability of these 
dyes is very high [10, 11]. Squarylium dyes can be highly fluorescent because of their 
planarity and rigidity due to the bridged polymethine chain. Introduction of reactive groups 
which enable covalent attachment to biomolecules, and of sulfonic acid groups which 
enhance water solubility of the dyes makes the squaraines viable labels for the use in 
biological applications. In addition, the quantum yields of the free dyes generally rise upon 
binding to biomolecules. The high quantum yields combined with the high molar absorbances 
of the squaraines result in a high brightness and a low detection limits of the conjugates [3, 
10-14]. Table 1.3 shows some selected squarylium dyes and their spectral properties. 
CHCH
O
O
YX
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Table 1.3. Some hydrophilic, reactive squarylium dyes, their absorption and emission 
maxima, molar absorbances (ε), and quantum yields (φ) in PBS [14, 15]. 
Structure 
λabs 
[nm]
λem 
[nm]
ε 
[L/mol·cm] 
φ 
(CH2)5
NN
CH CH
O
O
HO3S SO3H
CH3
COOH
630 647 85,000 0.03 
(CH2)5
COOH
(CH2)5
NN
CH CH
O
O
COOH
HO3S SO3H
661 680 140,000 0.05 
(CH2)5
COOH
(CH2)5
NN
CH CH
O
COOH
HO3S SO3H
C(CN)2
667 685 120,000 0.04 
Et(CH2)5
NN
CH CH
O
COOH
SO3H
NH
626 636 150,000 n.d. 
N
CH
S
CH
O
N
SO3H
(CH2)5
COOH
630 640 n.d. n.d. 
Et(CH2)5
NN
CH CH
S
COOH
SO3H
S
628 641 n.d. n.d. 
n.d.: not determined 
 
1.1.3. Labels 
There are several requirements for fluorescent biolabels. The fluorophore is expected to have 
a high molar absorbance and good solubility in water. Charged groups (usually anionic) are 
often introduced into the biolabel to avoid undesired electrostatic attraction to the 
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biomolecule. The fluorophore should be stable and soluble in organic solvents and in water. 
The fluorescence of the label should be weak in its unconjugated form and high if bound to 
the target. Fluorescence is expected to be pH-independent in the physiological range between 
pH 5 and 9. Besides, a high photostability and at least one reactive group for coupling to the 
target are required. 
 
1.2. Labeling 
The interest in bioanalysis focuses on analytes such as proteins and nucleic acids 
(DNA/RNA). In one of the actual bioanalytical indicator systems the molecule-specific probe 
is generated by coupling a detector molecule used for fluorescent signal generation. In order 
to obtain good signal-to-noise ratios, long-wave fluorophores are used because of reduced 
background fluorescence [16-18]. 
In the following some labeling methods for proteins and DNA are shown in brief. The 
use of labeled microparticles is not the main focus in this work, but must be mentioned for the 
sake of completeness. 
 
1.2.1. Labeling of Proteins 
Proteins and peptides are amino acid polymers containing a number of reactive side chains. 
Aliphatic ε-amino groups of the amino acid lysine and the α-amino groups of the N-terminal 
amino acids are the most common reactive groups of proteins. Reactive esters, especially 
oxysuccinimide (OSI) esters, are some of the most used reagents for amino group labeling. 
The labeling reaction competes favorably with hydrolysis of the active ester but the rates of 
both reactions depend on pH. Most labeling reactions with active esters are carried out 
between pH 8.5 and 9.5 over a period between 15 minutes and several hours (fig. 1.3 A). 
Isothiocyanates (fig. 1.3 B) are amine-modifying reagents of intermediate reactivity. They are 
somewhat more stable in water than OSI esters and react optimally with proteins at pH 9.0 – 
9.5. Sulfonylchlorides are highly reactive labels. They are unstable in water but form 
extremely stable sulfonamide bonds which can survive even amino acid hydrolysis (fig. 1.3 
C). 
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P NH2 FNCS P FNHCNH
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+
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O
NHFC
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O
O
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C
 
Figure 1.3. Common methods for labeling amino groups of proteins. A: the succinimidyl 
active ester method, B: the isothiocyanate method, C: the sulfonylchloride 
method. P denotes a protein, F a fluorophore. 
 
Another common reactive group in proteins is the thiol group of the amino acid cystein. The 
iodoacetamide (fig. 1.4. A), the maleimide (fig. 1.4. B), and the disulfide exchange method 
(fig. 1.4. C) are the most frequently used methods for thiol labeling. 
 
Figure 1.4. Common methods for thiol labeling. A: the iodoacetamide, B: the maleimide, 
and C the disulfide exchange method. P denotes a protein, F a fluorophore. 
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The carboxy acid groups of aspartic acid, glutamic acid and the C-terminal end of the peptide 
chain have only low activity in water and are therefore quite seldom used for labeling proteins 
[17, 19, 20]. 
 
1.2.2. Labeling of DNA 
There is a great interest in labeling oligonucleotides with fluorophores, because the resulting 
fluorescent oligonucleotides are needed for DNA sequencing and DNA hybridization studies. 
Reactive groups like in proteins are usually absent or not abundant in natural nucleic acids. A 
common method is to introduce a reactive group into the oligonucleotide. An amino group 
may be incorporated into a synthetic oligonucleotide as the last step in the synthesis process. 
Then the label can be introduced into the oligonucleotide via a reactive group such as an OSI 
ester which binds to amino groups. Most amine-reactive labels contain spacer groups (C4 – 
C6) in order to reduce the interaction of the label with the oligonucleotide [5, 21, 22]. 
Although phosphate groups of nucleotides and oligonucleotides are not very reactive 
in aqueous solution, their terminal phosphate groups can react with carbodiimides and similar 
reagents in combination with nucleophiles to yield phosphodiesters, phosphoramidates and 
phosphorothioates. However, the most important tagging method for DNA is based on the use 
of a phosphoramidite derivative of a fluorophore. In order to obtain phosphoramidite labels, 
the hydroxylated fluorophore (F-OH) is reacted with a phosphine I to give the 
phosphoramidite label II. The dye activated in this way couples to the hydroxy group of the 
(desoxy)ribose unit of an oligonucleotide to give III which, on oxidation with iodine, yields 
the labeled nucleotide IV (fig. 1.5.) [5, 24, 25]. 
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Figure 1.5. Scheme of the synthesis of fluorescently labeled nucleotides. F denotes a 
fluorophore, B a nucleobase. 
 
1.2.3. Dyeing of Microparticles 
Polystyrene beads (of 0.1-5 µm diameter) are widely used in immunoassays and in studies on 
receptor-ligand interactions, often in combination with flow cytometry. In recent years beads 
have been fluorescently dyed for purposes of encoding. The color of the fluorescence of the 
bead, the ratio of two fluorescence intensities of a bead, or the luminescence decay time of the 
fluorophore can serve for identification purposes [5]. 
It is possible to either covalently bind fluorescent dyes onto surface modified particles 
or to dissolve the dyes directly into the particles. For covalent coupling both the bead and the 
fluorophore need to possess functional groups for binding. In many cases the particles possess 
carboxy acid groups which are activated via the OSI ester method. Then amino-modified 
fluorophores can be attached to the surface. 
Liopophilic fluorophores with long alkyl chains (C18) are required for incorporating 
dyes inside beads. In most cases this method is preferred, because the interference of the dyes 
with the surface chemistry of the bead is reduced. Besides, there is more space available 
inside the particle than on its surface, so there is more incorporated fluorophore present which 
lowers the detection limit of the dyed bead [14]. 
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1.3. Fluorescence Resonance Energy Transfer (FRET) 
Fluorescence resonance energy transfer is transfer from the excited-state energy of the donor 
to an acceptor. Energy transfer occurs without the appearance of a photon. It is the result of 
long-range dipole-dipole interactions between donor and acceptor. The rate of energy transfer 
depends upon the extent of the spectral overlap of the emission spectrum of the donor with the 
absorption spectrum of the acceptor (see fig. 1.6.), the quantum yield of the donor, the relative 
orientation of the donor and acceptor transition dipoles, and the distance between donor and 
acceptor.  
450 500 550 600 650 700 750
0,0
0,2
0,4
0,6
0,8
1,0
overlap
acceptor
emission
     acceptor
absorbance
donor
emission
          donor
absorbance
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te
ns
ity
 [a
.u
.]
wavelength [nm]
 
Figure 1.6. The spectral overlap of the emission spectrum of the donor and the absorption 
spectrum of the acceptor. 
 
Energy transfer occurs over distances comparable to the dimensions of biological 
macromolecules. The distance at which FRET efficiency is 50% is called Förster distance 
(R0). R0 values are typically in the range of 2 - 6 nm. The rate of energy transfer (kT) from a 
donor to an acceptor is given by the following formula 
6
01 

=
r
R
k
D
T τ , (1.1) 
1. Introduction  12 
where τD is the decay time of the donor in absence of the acceptor, R0 is the Förster distance 
and r is the donor-to-acceptor distance. The rate of energy transfer strongly depends on the 
donor-to-acceptor distance being inversely proportional to r6 [2]. 
 
The Förster radius 0R  was calculated by the standard formula  
∫
∫=
)(
)()(
)2(8
9
4
44
2
6
0 λλ
λλσλλφππ
κ
d
d
d Fd
Fd
n
R ,  (1.2) 
where 2κ  is a factor accounting for the relative orientation of the emission and absorption 
dipoles of donor and acceptor, respectively; n is the refractive index of the solvent; ( )λdF  is 
the emission spectrum of the donor (in arbitrary units) at wavelength λ; and ( )λσ  is the 
absorption cross section of the acceptor which can be found from its extinction ( )λε  by 
( ) ( ) ( )λελελσ
AA NN
230310ln103 ≈⋅⋅= , (1.3) 
where AN  is the Avogadro-Loschmidt number. In the calculations, freely rotating donors and 
acceptors are assumed, so that for 2κ  the standard value of 32  can be adopted. The donor-
acceptor distance (r) can easily be calculated according to the following two formulae: 
66
0
6
0
rR
R
E +=  (1.4) 
and 
D
DA
F
FE −= 1 , (1.5.) 
where E is the efficiency of energy transfer, R0 is the Förster distance and FD and FDA are the 
relative fluorescence intensities of the donor in absence and in presence of the acceptor, 
respectively. [2] 
 
1.4. Immunoassays 
In this work, immunoassays were performed on the system HSA/anti-HSA which is described 
briefly in the following. 
 
1.4.1. The System HSA and Anti-HSA 
Human serum albumin (HSA) is an extremely abundant blood protein, forming about 50% of 
the total plasma protein in humans. HSA is composed of a single polypeptide chain and 
consists of 585 amino acids. It is 67% alpha-helical and does not contain any beta-sheet 
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structure. The protein has a molecular mass of 65,000 Dalton and contains 17 disulfide 
bridges. The primary function of HSA is to transport fatty acid molecules, but it also binds 
various metals, hormones, and a wide variety of drugs [26, 27]. 
 The role of HSA molecules which are present in blood plasma at about 0.6 mM is to 
increase the capacity of the circulatory system to carry fatty acids. Figure 1.7 shows an HSA 
molecule in its free form and complexed with fatty acid. The protein binds at least five fatty 
acid molecules which are only sparingly soluble in water because of their hydrophobic tails. 
The surface of HSA is very hydrophilic. This makes the protein very soluble in water [26].  
     
Figure 1.7. The structure of HSA in its free form and complexed with myristic acid (C14 
fatty acid) [26]. 
 
The antibody to HSA, anti-HSA, is an immunoglobulin G (IgG), also known as γ-globulin. It 
is developed in animal (e.g. rabbit, mouse, goat) using purified human albumin as the 
immunogen. Figure 1.8 shows the "Y"-shaped protein, composed of three fragments, two Fab 
fragments (the "arms" of the Y), and one Fc fragment (the "stem" of the Y) [28]. Each 
antibody has a molecular weight of approximately 150,000 Daltons and is composed of two 
identical heavy (dark and light blue) and two identical light chains (green and orange), all 
held together by disulfide bonds. In each chain there are constant domains and a variable 
domain. The four variable domains are positioned at the ends of the Y-like fork of the 
molecule where they form two binding sites for antigenic determinants. The carbohydrate 
(red) attached to the heavy chains aids in determining the destination of antibodies in tissues 
[27, 29, 30]. 
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Figure 1.8. The "Y"-structure of an IgG antibody [31]. 
 
In this work HSA/anti-HSA was chosen as the model system for immunoassays because 
serum albumin has long been used as a model protein and served for numerous applications in 
both industrial processes and academic research areas [32-34]. Anti-HSA is a quite stable 
antibody and can be stored at 2-8 °C for at least one month. Last but not least, HSA and anti-
HSA are relatively inexpensive. 
 
1.4.2. FRET Immunoassays 
Immunoassays constitute a large and diverse family of assays. At present, they are mainly 
based on fluorescence detection. Perhaps the most commonly used immunoassay format is the 
enzyme-linked immunosorbent assay (ELISA) owing to its high sensitivity and applicability 
to a wide range of antigens. ELISA is described as a heterogeneous assay. Antibodies are 
bound to a surface and separation steps are required. A major advantage is the use of 
homogenous assays, like FRET immunoassays. In this case separation steps are not required 
and sample handling is minimized. Such an assay is typically performed in a competitive 
format [2]. This means that for example the antigen is labeled with a fluorescent donor dye 
and the corresponding antibody is labeled with an acceptor dye. If non-labeled antigen is 
added, the donor labeled antigen is displaced and energy transfer efficiency is reduced. The 
acceptor dye can either be a quencher or, preferably, a fluorescent dye. If both donor and 
acceptor are fluorescent, ratiometric (2-wavelength) data evaluation is possible. 
 
1. Introduction  15 
1.5. Hybridization Assays 
Detection of DNA hybridization is often required in molecular biology, genetics, and 
forensics. A variety of methods has been used to detect DNA hybridization by fluorescence. 
Most of them rely on energy transfer between donor and acceptor labeled DNA. The presence 
of complementary DNA sequences can be detected by increased energy transfer when these 
sequences are brought into proximity by hybridization (fig. 1.9 A1 and A2). Competitive 
hybridization (fig. 1.9 B) in which increased amounts of non-labeled target DNA competes 
with the formation of donor-acceptor pairs can also be performed [2, 5]. "Molecular Beacons" 
(fig. 1.9 C) are not only of scientific interest, but can also be used to record hybridization of 
nucleic acids in homogeneous assays [35]. 
 
 
 
Figure 1.9. Some methods for studying the hybridization of oligonucleotides via FRET: 
binding studies (A1 and A2), competitive hybridization assays (B), and molecular 
beacons (C). 
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2. New Labels and Conjugates 
In this chapter, new long-wavelength excitable fluorescent labels and their conjugates are 
presented. The dyes belong to either the group of the cyanines or the squaraines. All dyes 
contain only one reactive group which avoids crosslinking. For the syntheses of amine-
reactive labels the NHS/DCC method was used, because the mild reaction conditions do not 
lead to decomposition of the dye and high yields (up to 70%) can be achieved. Furthermore, 
saccharide-reactive phosphoramidites (PAM) were synthesized which bind to the 5’-hydroxy 
group of the desoxyribose of oligonucleotides. The syntheses and the spectral properties of 
the dyes and their conjugates are described in the following. 
 
2.1. Cyanines 
In this work unsymmetrical cyanine labels have been developed. They contain one reactive 
oxysuccinimide (OSI) ester group which enables coupling to amino groups of biomolecules. 
All dyes also contain phosphonic acid groups and sometimes additional sulfo groups (FO548 
and FR646) to enhance their water solubility. This is important, because the labeling reaction 
of the OSI esters to the biomolecules is carried out in aqueous solution and measurements are 
performed in aqueous buffers. The dyes FO544, FO545, FO546, and FO548 are trimethine 
dyes. Their solutions are intensely pink colored. The acronym FO stands for "fluorescent 
orange", because the fluorescence of these labels is orange. FR642 and FR646 are 
pentamethines with blue color. They have red fluorescence which is considered by the 
acronym FR. 
 
2.1.1. FO544 
Synthesis 
The unsymmetrical monoreactive label FO544 can be synthesized via a four step reaction (fig. 
2.1). The first step is to quaternize 2,3,3-trimethyl-3H-indole (I) on the one hand with 
diethyl(2-bromoethyl)phosphonate [1], and on the other hand with ethyl-4-bromobutyrate to 
achieve the quaternized indoles II and III, respectively. Equimolar amounts of II and III are 
reacted with excess 1,1,1-trimethoxymethane in pyridine [2] to get the dye ethyl ester which 
is cleaved with K2CO3 in a methanol/water mixture to get the free acid of FO544. FO544-acid 
(IV) is separated from its byproducts (i.e. symmetrical dyes) by column chromatography. The 
reactive dye (V) is prepared by reacting the acid (IV) with NHS and DCC in dry acetonitrile 
[3]. 
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Figure 2.1. Synthesis of FO544 (V). 
 
Spectral Properties and Stability 
FO544 has an absorption maximum at 545 nm in PBS. The emission maximum is at 562 nm. 
It was found out that the OSI ester of the dye is very unstable in that the reactive dye is 
completely hydrolyzed in aqueous solution within approximately two hours. In methanol the 
dye is hydrolyzed, too, and the methyl ester is formed, a phenomenon which does not appear 
with the OSI esters of the other dyes. Even in solid form the OSI ester seems to decompose 
within a couple of days. 
 
2.1.2. FO545 
FO545 is an unsymmetrical monoreactive label. It has a very similar chemical structure to 
FO544, with the only difference that the spacer between the chromophore and the reactive 
group is prolonged by two methylene groups to examine if the stability of the OSI ester can 
be enhanced by changing the length of the spacer. 
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Synthesis 
FO545 can be synthesized by analogy to FO544 as described above. The only difference is to 
use 6-bromohexanoic acid instead of ethyl-4-bromobutyrate for the quaternization of the 
indole. In this case, of course, an ester hydrolysis with K2CO3 is not required. 
 
Spectral Properties of FO545 and its HSA Conjugates 
FO545 has an absorption maximum at 545 nm in PBS. The emission maximum is at 562 nm 
in PBS. The following molar absorbances were determined: ε545 nm (PBS) = 110,000 
L/(mol·cm), ε280 nm (PBS) = 11,000 L/(mol·cm), and ε260 nm (PBS) = 7,000 L/(mol·cm).  
 The absorption maximum shifts bathochromically to 553 nm and the emission 
maximum shifts to 573 nm upon covalent linkage to HSA. The quantum yield of the free dye 
in PBS is 0.03 and rises to 0.43 (DPR = 0.2) upon binding to HSA. DPR is the acronym for 
dye-to-protein ratio which is defined as the number of dye molecules per protein molecul. 
 Several FO545/HSA conjugates with various DPRs (0.2 - 4.2) were prepared to 
monitor the effect of the DPR on the fluorescence intensities and on the quantum yields. Two 
different types of measurements were performed either with constant dye concentration or 
with constant protein concentration. The fluorescence intensities of solutions with a constant 
dye concentration ([FO545] = 9.3·10-7 mol/L) were measured. Figure 2.2 shows the plot of the 
fluorescence intensities at the emission maximum versus the DPR. It is clearly visible that the 
fluorescence intensity decreases rapidly with increasing DPR. The quantum yield decreases 
from 0.43 at a DPR of 0.2 to 0.04 at a DPR of 3.3. 
0,0 0,5 1,0 1,5 2,0 2,5 3,0 3,5
0,0
0,2
0,4
0,6
0,8
1,0
1,2
flu
or
es
ce
nc
e 
in
te
ns
ity
 (λ
m
ax
) [
a.
u.
]
DPR
 
Figure 2.2. Plot of the fluorescence intensities of FO545/HSA conjugates at the emission 
maximum versus the DPR. [FO545] = 9.3·10-7 mol/L. 
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If the same measurement is carried out with a constant protein concentration  
([HSA] = 1.4·10-6 mol/L) the plot (fig. 2.3) looks totally different compared to that with 
constant dye concentration (fig. 2.2). It can be seen that saturation is reached at a DPR of 2. 
This means if more than two dye molecules are bound to one protein molecule the dye 
undergoes self-quenching. 
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Figure 2.3. Plot of the fluorescence intensities of FO545/HSA conjugates at the emission 
maximum versus the DPR. [HSA] = 1.4·10-6 mol/L. 
 
Stability 
The OSI ester of FO545 is much more stable than that of FO544. The reactive dye was 
dissolved in a methanol/water mixture and allowed to stand for 24 h at room temperature to 
prove the stability of the OSI ester. About 60% of the reactive dye were hydrolyzed within 
this time. In solid form the OSI ester is stable for a few weeks. 
 
2.1.3. FO546 
The chromophore of FO546 has the same structure as the chromophores of FO544 and 
FO545. The linker was prolonged by two methylene groups intending to further enhance the 
stability of the OSI ester. 
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Synthesis 
FO546 can be synthesized by analogy to FO544 as described above. 8-Bromooctanoic acid is 
used instead of ethyl-4-bromobutyrate for quaternization of the indole.  
 
Spectral Properties of FO546 and its Conjugates 
FO546 has an absorption maximum at 545 nm in PBS and an emission maximum at 560 nm. 
The following molar absorbances were determined: ε545 nm (PBS) = 86,000 L/(mol·cm),  
ε280 nm (PBS) = 7,000 L/(mol·cm), and ε260 nm (PBS) = 3,500 L/(mol·cm). 
 A solution of non-reactive FO546-acid ([FO546] = 6.3·10-7 mol/L) was titrated with 
various amounts of HSA (0-1000 mg/L) in order to find out if non-covalently conjugated 
HSA affects the fluorescence of FO546. Addition of 1000 mg/L HSA caused a two fold 
enhancement of the fluorescence intensity (fig. 2.4). The position of the fluorescence 
maximum is shifted by 3 nm to longer wavelengths. This effect is probably due to the fact that 
the dye interacts with the protein. It is possible that the dye moves into the hydrophobic 
domains of the protein. Then, the fluorophore is better shielded from the water molecules 
which are known to quench fluorescence, and on the other hand the dye is rigidized upon non-
covalent interaction with the protein. As a result, fluorescence intensity is enhanced. 
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Figure 2.4. Plot of the fluorescence intensities of FO546 at the emission maximum versus 
the concentration of the added HSA. [FO546] = 6.3·10-7 mol/L. λexc = 500 nm. 
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The absorption maximum shifts bathochromically to 553 nm and the emission maximum 
shifts to 564 nm upon covalent linkage to HSA. The quantum yield of the free dye in PBS is 
0.04 and rises to 0.08 when the dye is labeled to HSA with a DPR of 1.7. The absorption 
maximum shifts to 548 nm, and the emission maximum to 570 nm when the dye is covalently 
bound to anti-HSA. The quantum yield is 0.09 if FO546 is covalently bound to anti-HSA with 
DPR = 6.0.  
 The highest quantum yield measured (0.31) is reached by attaching FO546 covalently 
to an amino modified 15-mer oligonucleotide of sequence amino-5'-CCG GCA GCA AAA 
TGT-3'. The labeling conditions are similar to those when labeling HSA (see Exptl. Part, 
chapter 4.3.3.). The absorption maximum of the FO546/oligonucleotide conjugate is at 550 
nm, the emission maximum at 565 nm. The emission spectra of FO546 in its free form and 
some of its conjugates are shown in figure 2.5. Finally FO546 was covalently linked to the 
amino groups of the amino acids valin and aspartic acid. Not unexpectedly this did not lead to 
any changes in absorption and emission spectra. 
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Figure 2.5. Fluorescence spectra of FO546, FO546/HSA (DPR = 1.7), FO546/anti-HSA 
(DPR = 6.0), and FO546/oligonucleotide. λexc = 500 nm. 
 
Stability 
The stability of the FO546-OSI ester is very high. The reactive dye was dissolved in a 
methanol/water mixture and allowed to stand for 24 h at room temperature to prove the 
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stability of the OSI ester. Only 3% of the reactive dye were hydrolyzed within this time. In 
solid form the OSI ester seems to be stable at least for several months. 
 
2.1.4. FO548 
FO548 is an analogon to FO545 containing a sulfonic acid group attached to the benzene ring 
of the indole. This sulfo group is supposed to enhance the water solubility and to reduce non-
covalent binding of the fluorophore to protein. 
 
Synthesis 
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Figure 2.6. Synthesis of FO548 (VIII). 
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FO548 is synthesized in a six step reaction (see fig. 2.6) starting from 4-aminobenzene 
sulfonic acid (I) which is converted to the corresponding hydrazine derivative (II) via the 
diazo compound as an intermediate [4]. The 4-hydrazinobenzene sulfonic acid reacts to the 
corresponding indole (III) by a standard Fischer indole synthesis. The sulfonic acid group is 
then transformed into the potassium salt which is easier to purify. The next step is the 
alkylation of the indole with 6-bromohexanoic acid to introduce a carboxy acid as the reactive 
center (IV) [5]. 2,3,3-Trimethyl-3H-indole (V) is quaternized with diethyl(2-
bromoethyl)phosphonate to obtain the indole containing the phosphonic acid group (VI) [1]. 
Equimolar amounts of the indoles IV and VI are reacted with excess 1,1,1-
trimethoxymethane in pyridine to give FO548-acid (VII) [2] which is purified by column 
chromatography and then activated with NHS and DCC in dry DMSO to give the label VIII 
[3]. 
 
Spectral Properties of FO548 and its Conjugates 
FO548 has an absorption maximum at 548 nm and an emission maximum at 562 nm in PBS. 
The quantum yield of the free dye in PBS is 0.05. The following molar absorbances were 
determined: ε548 nm (PBS) = 155,000 L/(mol·cm), ε280 nm (PBS) = 21,000 L/(mol·cm), and  
ε260 nm (PBS) = 20,000 L/(mol·cm). 
 A solution of non-reactive FO548-acid ([FO548] = 1.4·10-6 mol/L) was titrated with 
various amounts of HSA (0-1000 mg/L) in order to find out if non-covalently conjugated 
HSA affects the fluorescence of FO548. Addition of HSA affected neither the fluorescence 
intensity nor the position of the fluorescence maximum. This effect can be attributed to the 
sulfo group in the molecule. At neutral pH FO548 carries three negative charges, one at the 
sulfo group, a second one at the phosphonic acid group, and a third one at the carboxy acid 
group. This results in an electronic repulsion of the anionic dye and the protein which also 
carries several negative charges at neutral pH. Therefore the influence of the protein on the 
fluorescence intensity of FR548 is not only reduced but even eliminated. 
 Covalent linkage to HSA does affect fluorescence intensities as well as the quantum 
yields and the positions of the absorption and emission maxima. The absorption maximum of 
the dye shifts to 556 nm, the emission maximum to 571 nm upon labeling to HSA (see fig. 
2.7). At low DPRs the quantum yields are high. At a DPR of 0.4 the quantum yield is 0.41 
and it decreases to 0.11 at a DPR of 7.2. 
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Figure 2.8. Fluorescence spectra of FO548 and FO548/HSA (DPR = 0.9 and 2.9). λexc = 520 
nm. 
 
FO548 was also covalently attached to a 15-mer oligonucleotide of sequence amino-5'-CCG 
GCA GCA AAA TGT-3'. The absorption maximum of the FO548/oligonucleotide conjugate 
is at 545 nm, the emission maximum at 569 nm. The quantum yield of the dye rises to 0.28 
upon binding to the oligonucleotide. 
 
2.1.5. FR642 
FR642 is an unsymmetrical pentamethine dye. It has a very similar structure to FO545 but the 
polymethine chain is prolonged by a vinyl group. 
 
Synthesis  
The unsymmetrical monoreactive label FR642 can be synthesized via a four step reaction (fig. 
2.8). The first step is to quaternize 2,3,3-trimethyl-3H-indole (I) on the one hand with 
diethyl(2-bromoethyl)phosphonate, and on the other hand with 6-bromohexanoic acid to 
achieve the quatenized indoles II and III, respectively. Equimolar amounts of II and III are 
reacted with excess 1,1,3,3-tetramethoxypropane in pyridine [2] to give FR642-acid (IV) 
which is separated from its byproducts (i.e. symmetrical dyes) by column chromatography. 
The reactive dye (V) is obtained by reacting the acid (IV) with NHS and DCC in dry DMSO 
[3]. 
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Figure 2.8. Synthesis of FR642 (V). 
 
Spectral Properties of FR642 and its Conjugates 
FR642 has an absorption maximum at 642 nm and an emission maximum at 660 nm in PBS. 
The quantum yield of the free dye in PBS is 0.17. The following molar absorbances were 
determined: ε642 nm (PBS) = 170,000 L/(mol·cm), ε280 nm (PBS) = 7,000 L/(mol·cm), and  
ε260 nm (PBS) = 8,000 L/(mol·cm). 
 A solution of the non-reactive FR642-acid ([FR642] = 3.6·10-7 mol/L) was titrated 
with various amounts of HSA (0-1000 mg/L) in order to find out whether non-covalently 
conjugated HSA affects the fluorescence of FR642. Addition of 1000 mg/L HSA raised the 
fluorescence intensity about three-fold (fig. 2.9). The position of the fluorescence maximum 
is shifted by 7 nm to longer wavelengths. The enhancement of the fluorescence intensity 
allows the speculation that FR642 may interact with HSA and move into the hydrophobic 
domains of the protein. There it is rigidized and shielded from the solvent molecules which 
might be the reason for the enhancement of the fluorescence intensity. 
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Figure 2.9. Plot of the fluorescence intensities of FR642 (free dye) at the emission 
maximum versus the concentration of the added HSA. [FR642] = 3.6·10-7 mol/L. 
λexc = 620 nm. 
 
The absorption maximum shifts bathochromically to 648 nm and the emission maximum 
shifts to 666 nm upon covalent linkage to HSA. FR642/HSA conjugates with various DPR 
(0.6 - 5.4) were prepared to show the influence of the DPR on the fluorescence intensity. Two 
different types of measurements were performed either with constant dye concentration or 
with constant protein concentration. Fluorescence intensities of solutions with a constant dye 
concentration ([FR642] = 5.9·10-7 mol/L) were measured. Figure 2.10 shows the plot of the 
fluorescence intensities at the emission maximum versus the DPR. It is clearly visible that 
fluorescence intensity decreases rapidly with increasing DPR. 
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Figure 2.10. Plot of the fluorescence intensities of FR642/HSA conjugates at the emission 
maximum versus the DPR. [FR642] = 5.9·10-7 mol/L. 
 
If the same measurement is carried out at a constant protein concentration ([HSA] = 1.7·10-6 
mol/L), the plot (fig. 2.11) looks totally different compared to that with constant dye 
concentration (fig. 2.10). It can be seen that at a DPR of about 1 the maximal intensity is 
reached. This demonstrates that binding of more than one dye molecule to one protein 
molecule leads to self-quenching. 
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Figure 2.11. Plot of the fluorescence intensities of FR642/HSA conjugates at the emission 
maximum versus the DPR. [HSA] = 1.7·10-6 mol/L. 
 
The absorption maximum shifts to 646 nm and the emission maximum to 665 nm if FR642 is 
labeled to anti-HSA. The quantum yield is 0.32 at a DPR of 0.7, 0.30 at a DPR of 1.3, and 
0.17 at a DPR of 5.9.  
 FR642 was also covalently attached to a 15-mer oligonucleotide. The quantum yield 
of FR642 rises to 0.22 upon covalent binding to the oligonucleotide. In this case the 
absorption maximum shifts to 647 nm, the emission maximum to 666 nm. Finally FR642 was 
covalently linked to the amino groups of the amino acids valin and aspartic acid. Not 
unexpectedly this did not lead to any changes in absorption and emission spectra. 
 
2.1.6. FR646 
FR646 is an analogon to FR642 containing a sulfonic acid group attached to the benzene ring 
of the indole [6]. This sulfo group is supposed to enhance the water solubility and to reduce 
non-covalent binding of the fluorophore to the protein. 
 
Synthesis 
The unsymetrical monoreactive label FR646 is synthesized in analogy to FR642 using 1-(5-
carboxypentyl)-2,3,3-trimethyl-3H-5-indoliumsulfonate instead of 1-(5-carboxypentyl)-2,3,3-
trimethyl-3H-indolium bromide. 
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Spectral Properties of FR646 and its Conjugates 
FR646 has an absorption maximum at 645 nm and an emission maximum at 664 nm in PBS. 
The quantum yield of the free dye in PBS is 0.20. The following molar absorbances were 
determined: ε646 nm (PBS) = 220,000 L/(mol·cm), ε280 nm (PBS) = 20,000 L/(mol·cm), and  
ε260 nm (PBS) = 24,000 L/(mol·cm). 
 A solution of non-reactive FR646-acid ([FR646] = 1.7·10-6 mol/L) was titrated with 
various amounts of HSA (0-1000 mg/L) in order to find out whether non-covalently 
conjugated HSA affects the fluorescence of FR646. Addition of HSA decreases the value of 
the fluorescence intensity to 80% (fig. 2.12). The position of the fluorescence maximum is 
shifted by 9 nm to longer wavelengths. This decrease in the quantum yield is in contrast to the 
behavior of all other dyes described in this work. 
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Figure 2.12. Plot of the fluorescence intensities of FR646 (free acid) at the emission 
maximum versus the concentration of the added HSA. [FR646] = 1.7·10-6 mol/L. 
λexc = 600 nm. 
 
The absorption maximum of FR646 shifts bathochromically to 646 nm and the emission 
maximum shifts to 664 nm upon covalent linkage to anti-HSA. The fluorescence intensities of 
the anti-HSA conjugates increase at a low DPR. Figure 2.13 shows a 1.9-fold increase of the 
fluorescence intensity at a DPR of 0.6 and a 1.7-fold increase at a DPR of 1.8. At a higher 
DPR (7.1) the fluorescence intensity even decreases slightly. The quantum yields decrease 
from 0.39 at a DPR of 0.6 to 0.20 at a DPR of 7.1. 
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Figure 2.13. Fluorescence spectra of FR646 and FR646/HSA (DPR = 0.6, 1.8, and 7.1). λexc = 
600 nm. 
 
Covalent coupling of FR646 to a 15-mer oligonucleotide shifts both the absorption maximum 
and the emission maximum 3 nm to longer wavelengths. 
 
2.2. Squaraines 
In additon to the cyanine labels described in 2.1, unsymmetrical squaraine labels have been 
developed. Both amine-reactive OSI esters and saccharide-reactive phosphoramidites have 
been synthesized. The squaraine labels like the cyanine labels contain only one reactive group 
to avoid crosslinking. The OSI esters (FR626, FR661, FR662, and FR670) are well soluble in 
aqueous solution and the PAM dyes (OB630 and OG670) are well soluble in chloroform 
which is important for labeling oligonucleotides in the last step of the automated synthesis 
process. The dyes FR626, FR661, and OB630 are conventional squarylium dyes, whereas 
FR662, FR670, and OG670 are derivatives of squaraines in which one oxygen atom of the 
squaric acid moiety is substituted by a dicyanomethylene group. 
 
2.2.1. FR626 
FR626 is an amine-reactive unsymmetrical squarylium dye. It contains a sulfo group to 
enhance water solubility. 
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Figure 2.14. Synthesis of FR626 (VIII). 
 
FR626 can be synthesized via a five step reaction [7]. First, potassium 2,3,3-trimethyl-3H-5-
indolesulfonate (I) is quaternized with ethyliodide. The sulfonated indolium derivative (II) 
and 3,4-dibutoxy-3-cyclobutene-1,2-dione (III) react in ethanol when catalytic amounts of 
triethylamine are present. The semi-substituted squaric acid derivative (IV) reacts with 1-(5-
                                                 
*  FR626 was synthesized by Bianca Wetzl, Institute of Analytical Chemistry, Chemo- and Biosensors, 
University of Regensburg, Germany. 
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carboxypentyl)-2,3,3-trimethyl-3H-indolium bromide (VI) which was synthesized by 
quaternation of 2,3,3-trimethyl-3H-indole (V) with 6-bromohexanoic acid to give FR626-acid 
(VII) which is purified by column chromatography. The OSI ester of the dye (VIII) is 
synthesized by activating the acid (VII) with NHS and DCC in acetonitrile. 
 
Spectral Properties of FR626 and its Conjugates  
FR626 has an absorption maximum at 626 nm and an emission maximum at 637 nm in PBS. 
The molar absorbance at the absorption maximum is 113,000 L/(mol·cm) and  
15,000 L/(mol·cm) at 280 nm. The quantum yield of the free dye in PBS is 0.02 and rises to 
0.17 if the dye is covalently attached to HSA at a DPR of 2.0. 
 
2.2.2. FR661 
FR661 is an unsymmetrical squaraine label which can be attached to amino groups. It 
contains an indolium and a quinolinium heterocycle. The presence of a lepidine (4-
methylquinoline) moiety causes a bathochromic shift of the absorption maximum of about 35 
nm compared to a squaraine containing two indolium heterocycles. 
 
Synthesis  
FR661 can be synthesized in a five step reaction. Lepidine (I) is quaternized with 6-
bromohexanoic acid in 1,2-dichlorobenzene. The quaternized lepidine (II) and 3,4-dibutoxy-
3-cyclobutene-1,2-dione react in ethanol containing catalytic amounts of triethylamine [in 
analogy to 8, 9, 10] to the semi-substituted squaric acid derivative (III). This reacts with 1-[2-
(diethoxyphosphoryl)ethyl]-2,3,3-trimethyl-3H-indolium bromide (V) which was synthesized 
by quaternization of 2,3,3-trimethyl-3H-indole (IV) with diethyl(2-bromoethyl)phosphonate 
[1] to give FR661-acid (VI) which is purified by column chromatography. The OSI ester of 
the dye (VII) is synthesized by activating the acid (VI) with NHS and DCC in an 
acetonitrile/DMF mixture. 
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Figure 2.15. Synthesis of FR661 (VII). 
 
Spectral Properties of FR661 and its Conjugates 
FR661 has an absorption maximum at 661 nm and an emission maximum at 725 nm in PBS. 
The Stokes' shift of 64 nm is remarkably large compared to those of the other squaraine and 
cyanine dyes presented in this work. Those dyes have Stokes' shifts of only 10-20 nm. It is 
known that dyes containing quinoline entities display comparably larger Stokes' shifts. The 
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molar absorbance of FR661 at the absorption maximum is 120,000 L/(mol·cm) and  
20,000 L/(mol·cm) at 280 nm. 
 The fluorescence of the free dye is very weak but rises upon addition of HSA. Figure 
2.16 shows the enhancement of the fluorescence intensity of FR661 upon addition of 
increasing amounts (0-4000 mg/L) of HSA. Addition of 4000 mg/L HSA to the dye solution 
causes a 13-fold increase compared to the fluorescence intensity of FR661 in PBS. 
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Figure 2.16. Plot of the fluorescence intensities of FR661 (free dye) at the emission 
maximum versus the concentration of the added HSA. λexc=660 nm. 
 
The fluorescence of FR661 is quenched almost completely (see figure 2.17) upon covalent 
attachment to HSA at a DPR of 1.9 Therefore, the dye is not suitable for labeling HSA and for 
the use in FRET studies. 
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Figure 2.17. Fluorescence spectra of FR661 and FR661/HSA (DPR=1.9). λexc=650 nm. 
 
Covalent attachment to aminoallyl-dUTP shifts the absorption maximum to 675 nm, the 
emission maximum to 729 nm. Figure 2.18 shows the excitation and emission spectra of 
FR661 and FR661/dUTP. The fluorescence intensity of FR661 increases more than three-fold 
upon labeling to dUTP but the quantum yields are still very low. 
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Figure 2.18. Excitation and emission spectra of FR661 and FR661/dUTP. λexc=650 nm. 
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2.2.3. FR662 
FR662 is a squarylium dye derivative in which one oxygen atom at the squaric acid moiety is 
substituted by a dicyanomethylene group [6, 11]. The dicyanomethylene group causes a 
bathochromic shift of the absorption maximum of about 35 nm. The label is amine-reactive 
and contains both a sulfo group and a phosphonic acid group which enhance the solubility of 
the fluorophore in aqueous media. 
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Figure 2.19. Synthesis of FR662 (VII). 
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Figure 2.19 shows the synthesis of FR662. First, one oxygen of squaric acid dibutylester (I) is 
subsituted by the reaction with malonodinitrile in THF. 2-(2,3-dibutoxy-4-oxo-2-
cyclobutenyliden)malonodinitrile (II) and the quaternized indole (III) react in ethanol 
containing catalytic amounts of triethylamine to the semi-substituted squaric acid derivative 
(IV). This reacts with the indole (V) to give FR662-butyl ester. The butyl ester is cleaved with 
HCl and the free acid (VI) is obtained. Activation to the reactive label (VII) is carried out in 
DMF using NHS and DCC. 
 
Spectral Properties of FR662 and its Conjugates 
FR662 has an absorption maximum at 662 nm and an emission maximum at 682 nm in PBS. 
The following molar absorbances were determined: ε662 nm (PBS) = 130,000 L/(mol·cm), 
 ε280 nm (PBS) = 8,000 L/(mol·cm), and ε260 nm (PBS) = 7,000 L/(mol·cm). The quantum yield 
of the free dye in PBS is 0.02. 
 A solution of non-reactive FR662-acid ([FR642] = 6.8·10-7 mol/L) was titrated with 
various amounts of HSA (0-1000 mg/L) in order to find out whether non-covalently 
conjugated HSA affects the fluorescence of FR662. Addition of 1000 mg/L HSA raised the 
fluorescence intensity about 8-fold (fig. 2.20). The position of the fluorescence maximum is 
shifted to 696 nm. Since FR662 contains both a sulfo group and a phosphonic acid group the 
dye carries several negative charges at neutral pH and is expected to be repulsed from the 
negatively charged protein. The dependence of the fluorescence intensity of the dye on the 
concentration of added HSA is surprisingly high, thus demonstrating that the dye interacts 
with HSA although both are negatively charged.  
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Figure 2.20. Plot of the fluorescence intensities of FR662 (free dye) at the emission 
maximum versus the concentration of added HSA. [FR662] = 6.8·10-7 mol/L. 
λexc = 640 nm. 
 
2.2.4. FR670 
FR670 is a monoreactive amino label. The structure of the chromophore is the same like that 
of FR662. FR670 contains one sulfo group to enhance water solubility. 
 
Synthesis 
FR670 can be synthesized in analogy to FR662 [6, 11]. The quaternized indole 1-ethyl-2,3,3-
trimethyl-3H-5-indoliumsulfonate is reacted with 2-(2,3-dibutoxy-4-oxo-2-cyclobutenyliden) 
malonodinitrile in ethanol containing catalytic amounts of triethylamine to give the semi-
substituted squaric acid derivative which is used without further purification. It reacts with 1-
(3-ethoxycarbonyl-propyl)-2,3,3-trimethyl-3H-indolium bromide to give FR670-butyl ester 
which is cleaved with NaOH. The free acid is activated in acetonitrile using NHS and DCC. 
 
Spectral Properties of FR670 and its Conjugates 
FR670 has an absorption maximum at 658 nm and an emission maximum at 676 nm in PBS. 
The quantum yield of the free dye in PBS is 0.03. The following molar absorbances were 
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determined: ε658 nm (PBS) = 145,000 L/(mol·cm), ε280 nm (PBS) = 15,000 L/(mol·cm),  
ε260 nm (PBS) = 14,000 L/(mol·cm). 
A solution of non-reactive FR670-acid ([FR670] = 3.8·10-7 mol/L) was titrated with various 
amounts of HSA (0-1000 mg/L) in order to find out if non-covalently conjugated HSA affects 
the fluorescence of FR670. Addition of 1000 mg/L HSA raised the value of the fluorescence 
intensity 5.6-fold (fig. 2.21.). The position of the fluorescence maximum is shifted to 700 nm. 
0 200 400 600 800 1000
0
1
2
3
4
5
6
7
8
9
flu
or
es
ce
nc
e 
in
te
ns
ity
 (λ
m
ax
) [
a.
u.
]
[HSA] [mg/L]
 
Figure 2.21. Plot of the fluorescence intensities of FR670 (free dye) at the emission 
maximum versus the concentration of added HSA. [FR670]= 3.8·10-7 mol/L. 
λexc=640 nm. 
 
The quantum yield of FR670/HSA is 0.08 at a DPR of 1.2 and decreases to 0.02 at a DPR of 
2.7. The dye undergoes self-quenching at high DPRs. At a DPR of 5 fluorescence is not 
detectable any more. 
 
2.2.5. OB630 
OB630 is a saccharide-reactive label. Such labels contain a phosphoramidite (PAM) group 
that binds to the 5’-hydroxy group of the desoxyribose of oligonucleotides. The squaraine is 
well soluble in chloroform which is important in the automated synthesis of labeled 
oligonucleotides. 
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Figure 2.22. Synthesis of OB630 (VII). 
 
OB630 can be synthesized via a four step reaction (fig. 2.22). First, 2-methylene-1,3,3-
trimethylindoline (II) and 3,4-dibutoxy-3-cyclobutene-1,2-dione (I) react in ethanol in 
presence of catalytic amounts of triethylamine [in analogy to 8, 9, 10] to give the butyl ester 
of the semi-substituted squaric acid derivative. The butyl ester is cleaved with NaOH in 
ethanol. The semi-substituted squaric acid derivative (III) reacts with 1-(6-hydroxyhexyl)-
2,3,3-trimethyl-3H-indolium bromide (V) which was synthesized by quaternation of 2,3,3-
trimethyl-3H-indole (IV) with 6-bromo-1-hexanol to give OB630-OH (VI) which is purified 
by column chromatography. Activation of the dye to the reactive phosphoramidite is carried 
out with 2-cyanoethyl-N,N,N',N',-tetraisopropyl-phosphordiamidite in dichloromethane with 
catalytic amounts of tetrazole [12]. 
 
Spectral Properties of OB630 and its Oligonucleotide Conjugates 
OB630 has an absorption maximum at 628 nm and an emission maximum at 637 nm in 
methanol. The following molar absorbances were determined: ε628 nm (MeOH) = 200,000 
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L/(mol·cm), ε280 nm (MeOH) = 10,000 L/(mol·cm), ε260 nm (MeOH) = 8,000 L/(mol·cm). The 
quantum yield of the free dye in methanol is 0.07 and rises to 0.25 if OB630 is labeled to a 
15-mer oligonucleotide. The absorption and emission maxima shift to 632 nm and 643 nm, 
respectively, in this case. 
 
2.2.6. OG670 
OB670 is another saccharide-reactive label. It has a chemical structure very similar to OB630 
with one oxygen atom at the squaric acid moiety substituted by a dicyanomethylene group. 
The dicyanometylene group causes a bathochromic shift of the absorption maximum of 40 
nm. 
 
Synthesis 
The synthesis of OG670 is carried out in complete analogy to the synthesis of OB630 using 2-
(2,3-dibutoxy-4-oxo-2-cyclobutenyliden)malonodinitrile instead of 3,4-dibutoxy-3-
cyclobutene-1,2-dione. 
 
Spectral Properties of OB670 and its Oligonucleotide Conjugates 
OB670 has an absorption maximum at 668 nm and an emission maximum at 687 nm in 
methanol. The following molar absorbances were determined: ε668 nm (MeOH) = 180,000 
L/(mol·cm), ε280 nm (MeOH) = 13,000 L/(mol·cm), ε260 nm (MeOH) = 12,000 L/(mol·cm). The 
quantum yield of the free dye in methanol is 0.09 and rises to 0.13 if OB630 is labeled to a 
15-mer oligonucleotide. The absorption and emission maxima shift to 667 nm and 681 nm, 
respectively, in this case. 
 
2.3. Non-covalent Protein Staining 
In previous sections it has been shown several times that some of the new dyes reported here 
undergo a strong increase in fluorescence intensity if contacted with HSA. This effect may be 
used to detect and visualize the presence of proteins via fluorescence, e.g. in electrophoretic 
protein separation or in proteomics in general. The following table 2.1 gives the dyes and the 
maximal enhancement effect on addition of HSA. It can be seen that the dyes FR661 and 
FR662 are most suitable in that respect. It should be noted, however, that this finding cannot 
be generalized, because many more proteins need to be studied first.  
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In addition dissociation constants KD* are listed in table 2.1. KD* is the concentration of HSA 
needed to bind half of the free dye. The value n gives the number of dye molecules bound per 
HSA. 
 
Table 2.1. Changes in Fluorescence Intensity of Free Dyes on Addition of Excess of Human 
Serum Albumin ([HSA] = 1000 mg/L), the Respective Dissociation Constants KD*, 
and the Number of Dye Molecules n Bound per HSA. 
 
Dye 
(carboxy form) 
Concentration of 
the Dye [mol/L] 
Change in Fluorescence 
Intensity 
KD* 
[mol/L] 
n 
FO546 6.3·10-7 2-fold enhancement 5.3·10-7 1.2 
FO548 1.4·10-6 no change -- -- 
FR642 3.6·10-7 3.1-fold enhancement 6.1·10-7 0.6 
FR646 1.7·10-6 20% decrease -- -- 
FR661 n.d. 8.4-fold enhancement 6.1·10-6 n.d. 
FR662 6.8·10-7 8.1-fold enhancement 6.8·10-7 1.0 
FR670 3.8·10-7 5.6-fold enhancement 4.6·10-7 0.8 
KD* values were determined graphically as described in chapter 4.5. 
 
The fluorescence intensities of the dyes FO546, FR642, FR661, FR662, and FR670 increase 
upon addition of HSA. The reason is that the dyes interact non-covalently with the protein. 
The chromophores might be attached onto the surface or in the hydrophobic domains of HSA. 
Fluorescence intensity increases, because on the one hand the fluorophore is shielded from the 
water molecules which are known to quench fluorescence, and on the other hand the dye is 
rigidized upon attachment to the protein and the degree of freedom of rotation and vibration is 
suppressed. This effect is quite strong in the case of the squaraine dyes where the fluorescence 
intensity rises up to 8-fold upon addition of 1000 mg/L HSA. The fluorescence of the 
cyanines FO546 and FR642 rises only 2- and 3-fold, respectively. In contrast, the cyanine dye 
FO548 is not affected at all, and FR646 shows even a small decrease of the fluorescence 
intensity upon addition of HSA. 
 
2.4. Conclusions 
The cyanines and the squaraines were chosen as a group of reactive labels because of their 
long-wavelengh absorbance and their relative small molecular size. All dyes contain only one 
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reactive group which avoids crosslinking. Various cyanine and squaraine labels were 
synthesized. The absorption maxima of the free dyes are in the range of 545 nm to 668 nm, 
the emission maxima are between 562 nm and 687 nm. The labels exhibit high molar 
absorbances between 86,000 L/(mol·cm) and 220,000 L/(mol·cm). Table 2.2 summarizes the 
structures and spectral properties of the newly synthesized labels. 
The fact that all labels are unsymmetrical dyes implies that the purification of the dyes 
is very sophisticated. A number of by-products are formed which have to be removed by 
column chromatography. The following digital photography (fig. 2.23) shows a 
chromatography column separating the raw product of an unsymmetrical dye. 
 
 
    
 
Figure 2.23. Photography of a chromatographic column separating the raw product in the 
synthesis of an unsymmetrical dye.
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Table 2.2. Overview of the structures and spectral properties of the synthesized labels. 
Name Structure 
λabs
[nm] 
λem 
[nm] 
ε 
[L/mol·cm] 
φ 
FO544 
CO
NN
(CH2)2
PO(O)(OEt)
(CH2)3
OSI  
545 562 n.d. n.d. 
FO545 
CO
NN
(CH2)2
PO(O)(OEt)
(CH2)5
OSI  
545 562 110,000 0.03 
FO546 
CO
NN
(CH2)2
PO(O)(OEt)
(CH2)7
OSI  
545 562 86,000 0.04 
FO548 
NNO3S
(CH2)2
PO(O)(OEt)
(CH2)5
CO
OSI  
548 562 155,000 0.05 
FR642 
N N
(CH2)2
PO(O)(OEt)
(CH2)5
CO
OSI  
642 663 170,000 0.17 
FR646 
NO3S N
(CH2)2
PO(O)(OEt)
(CH2)5
CO
ONHS  
646 664 220,000 0.20 
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FR626 
(CH2)5
O3S
N
CH
O
CH
N
OH
CO
OSI  
626 637 113,000 0.02 
FR661 N(CH2)5OC CH
O
CH
O
N
(CH2)2
PO(OEt)2
OSI
 
661 725 120,000 <0.005
FR662 
N
OH
C(CN)2
CH
(CH2)2
PO(OH)(OEt)
CH
N
(CH2)5
CO
SO3
OSI  
662 682 130,000 0.02 
FR670 
(CH2)3
CO
N
CH
O3S
CH
OH
C(CN)2
N
OSI  
658 676 145,000 0.03 
OB630* N
CH
O
CH
O
N
(CH2)6
OPAM  
628 637 200,000 0.07 
OG670* N
CH
C(CN)2
CH
O
N
(CH2)6
OPAM  
668 687 180,000 0.09 
* in methanol, others in PBS 
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Amine-Reactive Labels 
The amine-reactive labels all carry groups which enhance their water solubility. Therefore 
they are all satisfactorily soluble in aqueous solution. Precipitation of the dye/protein 
conjugates was not observed even at high DPRs. 
 A comparison of FO544, FO545, and FO546 which have quite similar spectroscopic 
properties shows that the chemical stability of the OSI esters of these dyes is strongly 
dependent on the length of the spacer groups. If the spacer is short (C3 in FO544) the stability 
of the OSI ester is low, if the spacer is long (C7 in FO546) the stability of the OSI ester is 
high both in solution and in solid state. Although it is possible to use freshly activated FO544 
and FO545 for labeling, the use of FO546 is preferred due to its stability in solid state over 
months. 
The fluorescence intensities of the labels (except FR661) generally increase upon 
covalent binding to protein. The extent of the increase is dependent on the dye-to-protein ratio 
(DPR). The highest quantum yields are found at DPR values between 1 and 2, because at 
higher DPRs the dyes undergo self-quenching, and fluorescence quantum yields decrease. 
Labeling to amino-modified oligonucleotides enhances the fluorescence intensities of the dyes 
up to 7-fold (FO546).  
  
Saccharide-Reactive Labels 
The saccharide-reactive phosphoramidites OB630 and OG670 are well soluble in chloroform. 
Their solubility in water is good enough to suppress precipitation of the labeled 
oligonucleotides in aqueous solution. The fluorescence intensities of OB630 and OG670 rise 
3.5- and 1.5-fold, respectively, upon labeling to 15-mer oligonucleotides. 
 
Energy Transfer Pairs 
All dyes described previously are promising labels for use in fluorescence resonance energy 
transfer (FRET) studiesbecause the emission spectra of the donor dyes efficiently overlap the 
absorption spectra of the acceptor dyes. Fluorescent acceptors are used instead of quenchers 
[13, 14] because in this case ratiometric data evaluation is possible. Ratiometric applications 
eliminate distortions of data caused e.g. by instrumental factors such as illumination stability 
or by changes of the probe concentration because of evaporation of solvent. 
The emission spectra of FO544, FO545, FO546, and FO548 sufficiently overlap the 
absorption spectra of FR642 and FR646. Any combination in which FO544, FO545, FO546, 
or FO548 serve as the donor dyes and FR642 or FR646 are used as acceptor dyes could be 
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used for FRET measurements. OB630 and OG670 can serve as donor-acceptor pair for 
oligonucleotide measurements.  
 FR646 and FR662 cannot be used as a donor-acceptor-pair, because the emission 
maxima of the two dyes are too close to each other. The resolution of both emission peaks is 
not possible because only one broad emission band is detected. In this case FR661 could be 
used as acceptor because of its large Stokes' shift. But the fluorescence of FR661 is very 
weak, and therefore ratiometric data evaluation is not possible in this case. FR662 can serve 
as acceptor dye if for example a ruthenium complex (e.g. [Ru(bpy)2(mcbpy)]) [15, 16] with 
an absorption maximum of about 450 nm and a large Stokes' shift is used as donor. 
 The use of the synthesized labels as donor–acceptor-pairs in FRET studies is shown in 
chapter 3. Immunoassays were performed as well as hybridization assays. 
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3. Applications 
This chapter deals with the applicability of the new labels presented in chapter two. The labels 
were used as donor and acceptor dyes in FRET studies. Binding studies of antigen-antibody 
complexes and homogenous immunoassays were performed using HSA/anti-HSA as a model 
system. Cytometric measurements for the quantification of HSA show the applicability of the 
labels in flow cytometry. In addition, various hybridization studies are shown: binding 
studies, determinations of molecular distances, and competitive assays. The applicability of a 
fluorescent dUTP in fluorescence in situ hybridization (FISH) is shown as well. 
 
3.1. Immunostudies 
In this work immunostudies were performed on the system HSA/anti-HSA. Binding studies, 
homogenous competitive immunoassays, and cytometric measurements are shown in the 
following. 
 
3.1.1. Binding Studies 
Binding studies were performed using various donor-acceptor pairs. Figure 3.1 shows how 
energy transfer can occur in this system. HSA (Ag) is labeled with the donor dye (orange), 
and anti-HSA (Ab) is labeled with the acceptor dye (red). When the antigen-antibody reaction 
takes place the complex is formed and labeled HSA occupies the specific binding sites at the 
labeled anti-HSA. Donor and acceptor come into close proximity and fluorescence resonance 
energy transfer can occur [1, 2]. 
 
 
 
Figure 3.1. Scheme for energy transfer on the system HSA/anti-HSA 
 
FO546/HSA-FR642/anti-HSA 
A representative binding study based on energy transfer measurements is shown in figure 3.2. 
HSA was labeled with FO546 at a DPR of 2.1. Anti-HSA was labeled with FR642 at a DPR 
of 2.5. FO546/HSA of constant concentration ([HSA] = 1.0·10-7 mol/L) was titrated with 
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various amounts of FR642/anti-HSA in molar ratios of 1:0, 1:0.25, 1:0.5, 1:1, 1:2, and 1:4. 
The fluorescence intensity of FO546/HSA decreases to 60% with increasing amounts of 
FR642/anti-HSA due to energy transfer. The fluorescence intensity of FR642/anti-HSA 
increases on the one hand due to the energy transfer, on the other hand due to the fact that the 
acceptor itself is directly photo-excited to a certain degree. Besides, fluorescence increases 
additionally with increasing amounts of acceptor. The fluorescence of FR642/anti-HSA 
without donor (0:4) is shown in figure 3.2. 
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Figure 3.2. Energy transfer study in which FO546/HSA (DPR = 2.1) of constant 
concentration was titrated with FR642/anti-HSA (DPR = 2.5) (λexc = 520 nm). 
[HSA] = 1.0·10-7 mol/L. 
 
Figure 3.3 shows the fluorescence spectra of FO546/HSA (DPR = 2.1) of constant 
concentration ([HSA] = 1.0·10-7 mol/L) titrated with increasing amounts of free FR642. Molar 
ratios are 1:0, 1:0.625, 1:1.25, 1:2.5, 1:5, and 1:10 and correspond to the concentrations of 
FR642 in the binding study shown in figure 3.2. This measurement was performed in order to 
find out wether free acceptor dye affects the fluorescence of the donor labeled HSA. The 
fluorescence intensity of FO546/HSA is reduced to 90% upon addition of a ten-fold excess of 
free FR642. The fluorescence intensity of FR642 increases with increasing amounts of 
FR642. Measurement of the fluorescence intensity of FR642 without FO546/HSA (0:10) 
shows that this increase is mainly caused by direct excitation of the acceptor and only a small 
part contributes to energy transfer. 
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Figure 3.3. Fluorescence spectra of FO546/HSA (DPR = 2.1) of constant concentration 
titrated with free FR642 (λexc = 520 nm). [HSA] = 1.0·10-7 mol/L. 
 
The effect of non-labeled anti-HSA on the fluorescence of FO546/HSA (DPR = 2.1) was 
proved in addition. FO546/HSA of constant concentration ([HSA] = 1.0·10-7 mol/L) was 
titrated with various amounts of anti-HSA in molar ratios of 1:0, 1:0.25, 1:0.5, 1:1, 1:2, and 
1:4. No effect was observed of the anti-HSA concentration on fluorescence intensity.  
 Figure 3.4 shows ratiometric plots of the three measurements. The fluorescence 
intensities at 664 nm are divided by the fluorescence intensities at 569 nm. These values are 
plotted versus the ratio of the concentration of the titrators (FR642/anti-HSA, FR642, or anti-
HSA) and the concentration of FO546/HSA. It is clearly visible that non-labeled anti-HSA 
(blue line) has no effect on the fluorescence of FO546/HSA. On addition of free FR642 a 
raise of the ratio of the fluorescence intensities appears (red line). A straight line would be 
achieved if there was no energy transfer and if only the fluorescence intensity of the acceptor 
alternated and the fluorescence of the donor was constant. The curve obtained in this case is 
not exactly straight which might tribute to the fact that a small part of the free acceptor 
molecules bind non-covalently to the donor labeled HSA molecules whereupon energy 
transfer can take place to a certain extent. It is expected that on addition of FR642/anti-HSA 
to FO546/HSA a sigmoidal binding curve should be obtained. In this case only a part of the 
binding curve is visible. The point of saturation, this means the point where addition of more 
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acceptor labeled anti-HSA causes no changes in the ratio of the fluorescence intensities is not 
visible. 
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Figure 3.4.  Ratiometric plot of the ratios of the fluorescence intensities at 664 nm and 569 
nm versus the ratios of the concentrations of titrators (FR642/anti-HSA, FR642, 
or anti-HSA) and the concentration of FO546/HSA. 
 
Figure 3.5 and figure 3.6 show another binding study on the system FO546/HSA-FR642/anti-
HSA. Here the DPR of FO546/HSA has been reduced to 1.7 and the DPR of FR642/anti-HSA 
has been raised to 5.9. In this case the fluorescence of FR642/anti-HSA caused by direct 
excitation and not by energy transfer is small because at high DPR the quantum yield of the 
dye is weak (see figure 3.5; 0:4). The fluorescence intensity of the donor decreases to 40% 
upon addition of a four-fold excess of FR642/anti-HSA (fig. 3.5; 1:4) compared to the 
intensity without acceptor (fig. 3.5; 1:0). The fluorescence intensity of the acceptor (fig. 3.5; 
1:4) increases more than eight-fold compared to the fluorescence of FR642/anti-HSA without 
donor (fig. 3.5; 0:4). 
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Figure 3.5. Energy transfer study in which FO546/HSA (DPR = 1.7) of constant 
concentration was titrated with FR642/anti-HSA (DPR = 5.9) (λexc = 520 nm). 
[HSA] = 1.0·10-7 mol/L. 
 
The plot of the ratios of the fluorescence intensities at 664 nm and 568 nm versus the ratios of 
the concentration of FR642/anti-HSA and of FO546/HSA gives a sigmoidal curve. Saturation 
is nearly reached at a four-fold excess of FR642/anti-HSA. 
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Figure 3.6.  Plot of the ratios of the fluorescence intensities at 664 nm and 568 nm versus the 
ratios of the concentrations of FR642/anti-HSA and the concentration of 
FO546/HSA. 
 
In the energy transfer system shown in figure 3.4 (black line) almost equal DPRs of the donor 
and acceptor conjugates, respectively, were used. In contrast, in the system shown in figure 
3.6, the DPR of the acceptor conjugate is much higher than that of the donor conjugate. This 
system gives a sigmoidal binding curve which is preferred to the curve obtained in figure 3.4. 
 
FO548/HSA-FR646/anti-HSA 
Figure 3.7 shows an energy transfer study on the system FO548/HSA-FR646/anti-HSA. HSA 
was labeled with FO548 at a DPR of 3.6. Anti-HSA was labeled with FR646 at a DPR of 1.5. 
FO548/HSA of constant concentration ([HSA] = 2.0·10-8 mol/L) was titrated with various 
amounts of FR646/anti-HSA in molar ratios of 1:0, 1:0.25, 1:0.5, 1:1, 1:2, and 1:4. The 
fluorescence intensity of the donor decreases to 50% upon addition of a four-fold excess of 
FR646/anti-HSA (fig. 3.7; 1:4) compared to the intensity without acceptor (fig. 3.7; 1:0). The 
fluorescence intensity of the acceptor (fig. 3.7; 1:4) increases nearly three-fold compared to 
the fluorescence of FR646/anti-HSA without donor (fig. 3.7; 0:4). The ratiometric plot 
(fig.3.7, right) shows the sigmoidal binding curve of the system. 
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Figure 3.7. Energy transfer study in which FO545/HSA (DPR = 3.6) of constant 
concentration was titrated with FR646/anti-HSA (DPR = 1.5) (λexc = 520 nm). 
[HSA] = 2.0·10-8 mol/L. 
 
[Ru(bpy)2(mcbpy)]/HSA-FR662/anti-HSA 
In figure 3.8 an energy transfer study is shown in which a ruthenium complex serves as the 
donor dye. It should be mentioned that the donor is not fluorescent but phosphorescent. The 
ruthenium complex [Ru(bpy)2(mcbpy)](PF6)2 [3, 4, 5] shown in figure 3.8 on the right side 
was activated to the OSI ester by standard methods and was labeled to HSA with a DPR of 
10.3. The absorption maximum of the conjugate is at 460 nm and the emission maximum is at 
635 nm, i.e. the Stokes' shift is as large as 175 nm. The acceptor FR662 was labeled to anti-
HSA with a DPR of 7.8. [Ru(bpy)2(mcbpy)]/HSA of constant concentration ([HSA] = 1.3·10-7 
mol/L) was titrated with various amounts of FR662/anti-HSA in molar ratios of 1:0, 1:0.125, 
1:0.25, 1:0.5, 1:1, 1:2, and 1:4. The emission intensity of the donor decreases to 30% upon 
addition of a four-fold excess of FR662/anti-HSA (fig. 3.8; 1:4) compared to the intensity 
without acceptor (fig. 3.8; 1:0). The fluorescence intensity of the acceptor in absence of donor 
(fig. 3.8; 0:4) is negligible, because the acceptor is not photo-excited at 460 nm. 
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Figure 3.8. Energy transfer study in which [Ru(bpy)2(mcbpy)]/HSA (D/P = 10.3) of constant 
concentration was titrated with FR662/anti-HSA (D/P = 7.8) (λexc = 460 nm). 
[HSA] = 1.3·10-7 mol/L. The chemical structure of the ruthenium complex 
[Ru(bpy)2(mcbpy)](PF6)2 is shown on the right side. 
 
The plot of the ratios of the emission intensities at 693 nm and 635 nm versus the ratios of the 
concentration of FR662/anti-HSA and of [Ru(bpy)2(mcbpy)]/HSA gives a sigmoidal curve 
(fig. 3.9). At a two-fold excess of FR662/anti-HSA saturation is nearly reached. 
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Figure 3.9.  Ratiometric plot of the ratios of the fluorescence intensities at 693 nm and 635 
nm versus the ratios of the concentrations of FR662/anti-HSA and the 
concentration of [Ru(bpy)2(mcbpy)]/HSA. 
 
3.1.2. Competitive Immunoassays 
Competitive homogenous immunoassays on the system HSA/anti-HSA were performed using 
various donor/acceptor pairs. Figure 3.10 shows the scheme for the competitive 
immunoassay. Constant amounts of donor labeled HSA (Ag) were mixed with various 
quantities of non-labeled HSA (analyte). These solutions were diluted to a constant volume 
with PBS. An equal amount of acceptor labeled anti-HSA (Ab) was added and the solutions 
were incubated for 20 minutes at room temperature to allow the formation of the antigen-
antibody complex. 
 
 
Figure 3.10. Scheme for the competitive immunoassay on the system HSA/anti-HSA. 
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Labeled and non-labeled HSA compete for the specific binding sites at the labeled antibody. 
If the fraction of non-labeled HSA is low, mainly labeled HSA binds to the labeled anti-HSA 
and energy transfer can occur. This leads to a decrease of the fluorescence intensity of the 
donor and an increase of the fluorescence intensity of the acceptor. If the fraction of non-
labeled HSA is high, mainly non-labeled HSA binds to anti-HSA and energy transfer is 
reduced. This leads to an increase of the fluorescence intensity of the donor and to a decrease 
of the fluorescence intensity of the acceptor [1]. FRET immunoassays open the way to 2-
wavelength immunoassays which are intrinsically self-referenced, because the signal is 
calculated from the fluorescence intensities at two wavelengths. Some examples for 
competitive homogenous immunoassays are shown in the following. 
 
FO546/HSA-FR642/anti-HSA 
Constant quantities of FO546/HSA with a DPR of 2.1 ([FO546/HSA] = 8.3·10-8 mol/L) were 
mixed with various quantities of non-labeled HSA in molar ratios of 1:0, 1:0.25, 1:0.5, 1:1, 
1:2, and 1:3. Constant amounts of FR642/anti-HSA with a DPR of 2.5 were added 
([FR642/anti-HSA] = 8.3·10-8 mol/L). Figure 3.11 (left) shows the plot of the fluorescence 
intensities versus the wavelength. The fluorescence intensity of the donor increases with 
increasing amounts of non-labeled HSA. The decrease of the acceptor fluorescence is not 
visible in this case. 
 The ratiometric plot is shown on the right side of figure 3.11. The ratio of the 
fluorescence intensities of the donor and the acceptor is plotted versus the ratio of the 
concentrations of non-labeled HSA and FO546/HSA. A sigmoidal binding curve is achieved. 
The use of this system enables determination of HSA in the concentration range of 4·10-8 – 
2.4·10-7 mol/L. The concentration range was determined graphically. 
 The measurement was repeated using BSA instead of HSA in order to prove if protein 
which does not compete with FO546/HSA for the binding sites of FR642/anti-HSA affects 
the immunoassay system. In figure 3.11 (right side, red line) it can bee seen that addition of 
BSA has no effect on the FRET efficiency of the immunosystem. 
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Figure 3.11. Left side: Competitive immunoassay in which FO546/HSA (DPR = 2.1) of 
constant concentration ([FO546/HSA] = 8.3·10-8 mol/L) was mixed with 
various amounts of non-labeled HSA and constant quantities of FR642/anti-
HSA (DPR = 2.5) ([FR642/anti-HSA] = 8.3·10-8 mol/L). λexc = 520 nm. 
 Right side: Ratiometric plot of the immunoassay (black line) and the negative 
control (red line on bottom). 
 
Figure 3.12 shows another immunoassay on the system FO546/HSA-FR642/anti-HSA. Here 
the DPR of FO546/HSA has been reduced to 1.7 and the DPR of FR642/anti-HSA has been 
raised to 5.9. Constant quantities of FO546/HSA ([FO546/HSA] = 8.3·10-8 mol/L) were 
mixed with various quantities of non-labeled HSA in molar ratios of 1:0, 1:0.25, 1:0.5, 1:1, 
1:2, and 1:4. Constant amounts of FR642/anti-HSA were added ([FR642/anti-HSA] = 8.3·10-8 
mol/L). Figure 3.12 (left side) shows the plot of the fluorescence intensities versus the 
wavelength. The increase of the fluorescence intensity of the donor upon addition of non-
labeled HSA is much stronger in this case compared to the assay in figure 3.11. In fact, a 
slight decrease of the fluorescence intensity of the acceptor is visible. 
 The ratiometric plot is shown on the right side of figure 3.12. The ratio of the 
fluorescence intensities of the donor and the acceptor is plotted versus the ratio of the 
concentrations of non-labeled HSA and FO546/HSA. A sigmoidal binding curve is obtained. 
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The use of this system enables determination of HSA in the concentration range of 2·10-8 – 
1.6·10-7 mol/L which was evaluated graphically.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.12. Left side: Competitive immunoassay in which FO546/HSA (DPR = 1.7) of 
constant concentration ([FO546/HSA] = 8.3·10-8 mol/L) was mixed with 
various amounts of non-labeled HSA and constant quantities of FR642/anti-
HSA (DPR = 5.9) ([FR642/anti-HSA] = 8.3·10-8 mol/L). λexc = 520 nm.  
 Right side: Ratiometric plot. 
  
FO548/HSA-FR646/anti-HSA 
Two homogenous competitive immunoassays based on the system FO548/HSA-FR646/anti-
HSA are shown in figure 3.13 and 3.14. Constant amounts of FO548/HSA with a DPR of 3.6 
were mixed with various quantities of non-labeled HSA in molar ratios of 1:0, 1:0.125, 
1:0.25, 1:0.5, 1:1, 1:2, and 1:4. Constant quantities of FR642/anti-HSA with a DPR of 1.5 
were added. The assay shown in figure 3.13 contains equimolar amounts of labeled HSA and 
anti-HSA ([FO548/HSA] = [FR642/anti-HSA] = 1.7·10-8 mol/L). The assay shown in figure 
3.14 contains a two-fold excess of labeled anti-HSA ([FO548/HSA] = 1.4·10-8 mol/L, 
[FR642/anti-HSA] = 2.8·10-8 mol/L). The left sides in figures 3.13 and 3.14 show the plots of 
the fluorescence intensities versus the wavelength. In both assays the fluorescence intensity of 
the donor increases with increasing fractions of non-labeled HSA while the fluorescence 
intensity of the acceptor decreases. 
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The ratiometric plots are shown on the right sides in figures 3.13 and 3.14. The ratio of the 
fluorescence intensities of the donor and the acceptor is plotted versus the ratio of the 
concentrations of non-labeled HSA and FO548/HSA. Sigmoidal binding curves are obtained. 
The slope of the binding curve in figure 3.13. is high at concentration ratios in the range of 
0.125 - 2. This enables determination of HSA in the concentration range of 2·10-9 – 3.5·10-8 
mol/L. At higher concentrations of HSA the slope of the binding curve is low, because 
saturation is nearly reached. Accurate determinations of HSA concentrations in this 
concentration range are not possible. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.13. Left side: Competitive immunoassay in which FO548/HSA (DPR = 3.6) of 
constant concentration ([FO548/HSA] = 1.7·10-8 mol/L) was mixed with 
various amounts of non-labeled HSA and constant quantities of FR646/anti-
HSA (DPR = 1.5) ([FR642/anti-HSA] = 1.7·10-8 mol/L). λexc = 520 nm.  
 Right side: Ratiometric plot of the immunoassay. 
 
The slope of the binding curve in figure 3.14 at low HSA concentrations is lower than that in 
figure 3.13, indicating that at low HSA concentrations (2·10-9 – 3·10-8 mol/L) the system 
shown in figure 3.13 is favored. At higher HSA concentrations (3·10-8 – 5.5·10-8 mol/L) the 
system shown in figure 3.14 is favored, because at a four-fold excess of HSA still saturation is 
not reached. 
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Figure 3.14. Left side: Competitive immunoassay in which FO548/HSA (DPR=3.6) of 
constant concentration ([FO548/HSA] = 1.4·10-8 mol/L) was mixed with 
various amounts of non-labeled HSA and a two-fold excess of FR646/anti-
HSA (DPR=1.5) ([FR642/anti-HSA] = 2.8·10-8 mol/L). λexc=520 nm.  
 Right side: Ratiometric plot. 
 
3.1.3. Cytometric Measurements 
Flow cytometry allows the simultaneous quantitative measurement of up to 100 different 
diagnostic parameters in a single drop of a sample (LuminexTM technology). At the same time 
it may even save time compared to a single parameter measurement using conventional 
methods. Due to its high flexibility, the technology can be used to measure numerous 
diagnostic analytes if it undergoes a specific molecular interaction with a partner molecule, 
e.g. an antibody, an enzyme or a substrate, any ligand or receptor, or a complementary nucleic 
acid.  
 The antigen-antibody interaction takes place on the surface of the microspheres. The 
extent to which the antibody has interacted with the immobilized antigen is measured using a 
fluorescent label. Usually, polystyrene particles serve as a solid phase. Thousands of 
microspheres are analyzed per second individually. The kind of assay may be encoded as well 
by rendering the beads fluorescent using a second (encoding) color that typically has a red 
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fluorescence. Flow cytometric assays involve less washing steps, enable working with whole 
blood, and can be fully programmed. Hence, they represent a substantial advantage over 
previous assays protocols. [6] 
 The assay is demonstrated using the system HSA/anti-HSA. Figure 3.15 shows the 
antigen-antibody system attached to the surface of the microsphere. 
 
Figure 3.15. Scheme of a bead carrying the antigen-antibody system. 
 
Polystyrene beads of 5.4 µm diameter were activated with sulfo-NHS and EDC. The reactive 
particles were incubated with HSA solutions of various concentrations (0-500 µg/mL). Anti-
HSA was labeled with FO548 at a DPR of 2.1. The beads loaded with HSA were then 
incubated with solutions of labeled antibody. The concentrations of the anti-HSA solutions 
were in the range of 0-131 µg/mL. The beads were washed and submitted to the flow 
cytometer. HSA is detectable in the 10 - 120 µg/mL concentration range as can be seen from 
figure 3.16. 
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Figure 3.16. Flow cytometric assay of HSA using FO548 labeled anti-HSA. 
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3.2. Hybridization Studies 
Various hybridization studies were performed. In the following, binding studies and 
homogenous competitive hybridization studies based on FRET are shown. In these cases 15-
mer oligonucleotides were labeled with saccharide reactive PAMs, or amino-modified 
oligonucleotides were labeled with OSI esters. (The sequences of the oligonucleotides can be 
found in chapter 4.1.1). 
 
3.2.1. Binding Studies 
FO548/oligo1-FR646/oligo3 
Various energy transfer systems were tested. A representative energy transfer measurements 
is shown in figure 3.17. FO548 was labeled to the 5'-end of an amino-modified 15-mer 
oligonucleotide (oligo1). FO646 was labeled to the 3'-end of a complementary amino-
modified 15-mer oligonucleotide (oligo3). The donor FO548/oligo1 of constant concentration 
([FO548/oligo1] = 2·10-7 mol/L) was titrated with various amounts of acceptor FR646/oligo3. 
Molar ratios are 1:0, 1:0.25, 1:0.5, 1:0.75, 1:1, 1:2, and 1:4. The fluorescence intensity of 
FO548/oligo1 decreases to 9% with increasing amounts of FR646/oligo3 and the fluorescence 
intensity of FR646/oligo3 increases due to energy transfer. 
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Figure 3.17. Energy transfer study in which FO548/oligo1 of constant concentration 
([FO548/oligo1] = 2·10-7 mol/L) was titrated with FR646/oligo3 (λexc = 520 nm). 
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Figure 3.18 shows the plot of the ratio of the fluorescence intensities at 668 nm and 568 nm 
versus the ratio of the concentration of FR646/oligo3 and the concentration of FO548/oligo1 
(black line). In addition, ratiometric plots of a titration of FO548/oligo1 with free FR646 (red 
line) and with non-labeled complementary oligonucleotide (oligo3) (blue line) are shown. It is 
clearly visible that the influence of free acceptor and of non-labeled oligonucleotide on the 
energy transfer is negligible.  
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Figure 3.18. Plot of the ratio of the fluorescence intensities at 668 nm and 568 nm versus the 
ratio of the concentration of titrators (FR646/oligo3, FR646, or oligo3) and the 
concentration of FO548/oligo1. 
 
The R0 value and the average distance between the donor and the acceptor molecules were 
calculated according to the method described in capter 1.3. The R0 value of the system 
FO548/oligo1-FR646/oligo3 is 5.9 nm. The average distance between the donor and the 
acceptor is 4.0 nm.  
 
OB630/oligo5-OG670/oligo4 
Two complementary oligonucleotides were labeled at the respective 5'-ends, the one with the 
phosphoramidite OB630 (oligo5), and on the other with the phosphoramidite OG670 (oligo4). 
Figure 3.19 shows the titration of the donor OB630/oligo5 at constant concentration 
([OB630/oligo5] = 2·10-7 mol/L) with various amounts of acceptor OG670/oligo4. Molar 
ratios are 1:0, 1:0.25, 1:0.5, 1:1, 1:2, and 1:4. The fluorescence intensity of OB630/oligo5 
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decreases to 40% with increasing amounts of OG670/oligo4. The fluorescence spectrum of 
OG670/oligo4 without donor (fig. 3.19; orange line) shows that the acceptor is directly 
excited at 600 nm. The fluorescence of the acceptor increases not only due to an increase in 
energy transfer but also due to higher concentration. The ratiometric plot of the measurement 
is shown on the right side of figure 3.19. At a four-fold excess of OG670/oligo4 saturation is 
nearly reached. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.19. Energy transfer study in which OB630/oligo5 of constant concentration 
([OB630/oligo5] = 2·10-7 mol/L) was titrated with OG670/oligo4 (λexc = 600 
nm). 
 
The R0 value of the system OB630/oligo5-OG670/oligo4 was calculated to be 6.3 nm. The 
average distance between the donor and the acceptor molecules is 6.0 nm. 
 
FO546/oligo1-FR642/oligo2 and FO546/oligo1-FR642/oligo3 
The donor FO546/oligo1 was titrated with acceptor FR642/oligo2 (fig. 3.20) and 
FR642/oligo3 (fig. 3.21), respectively. The fluorescence intensity of the donor decreases to 
55% (fig. 3.20) and 13% (fig. 3.21), respectively, with increasing quantities of acceptor, while 
the fluorescence intensity of the acceptor increases due to energy transfer. In both cases the 
donor dye FO546 is labeled to the 5'-end of oligo1. In figure 3.20 the acceptor is attached to 
the 5'-end, in figure 3.21 to the 3'-end of the complementary oligonucleotide. The decreased 
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energy transfer efficiency (figure 3.20) in comparison to that shown in figure 3.21 shows that 
the donor-acceptor distance is much larger in case of 5'-5' labeling. 
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Figure 3.20. Energy transfer study in which FO546/oligo1 of constant concentration 
([FO546/oligo1] = 1.0·10-7 mol/L) was titrated with FR642/oligo2 (λexc = 530 
nm). 
 
The R0 value of the system FO546/oligo1-FR642/oligo2 was calculated to be 5.8 nm. The 
average distance between the donor and the acceptor molecules is 5.5 nm. The calculations 
were carried out according to the method described in chapter 1.3. 
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Figure 3.21. Energy transfer study in which FO546/oligo1 ([FO546/oligo1] = 1.0·10-7 mol/L) 
was titrated with FR642/oligo3 (λexc = 530 nm). 
 
The R0 value of the system FO546/oligo1-FR642/oligo3 was calculated to be 5.9 nm. The 
average distance between the donor and the acceptor molecules is 4.3 nm. 
 Figure 3.22 shows the so-called binding curves, the plot of the ratio of the two peak 
intensities versus the concentration ratio of the labeled oligonucleotides. In both cases 
saturation of the curve is nearly reached at a two-fold excess of acceptor. The energy transfer 
rate is much higher if FR642/oligo3 is used as acceptor instead of FR642/oligo2, because in 
this case the distance between donor and acceptor is much shorter.  
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Figure 3.22. Plot of the ratio of the fluorescence intensities at 667 nm and 565 nm versus the 
ratio of the concentration of titrators (FR642/oligo2 and FR642/oligo3) and the 
concentration of FO546/oligo1. 
 
The Förster radii (R0) of the donor-acceptor pairs are summarized in table 3.1. They all are 
around 6 nm. In comparison to existing systems (2.2 nm in [7], 4.9 nm in [8]), the R0 values 
of the used dye pairs are higher which enables energy transfer measurements over larger 
distances. This is of special significance in case of 5'-5' labeling. If the R0 values were 
smaller, the energy transfer efficiency would be to low to be detected. 
The average distances between the donor and acceptor molecule were computed using 
these R0 values. If the position of the labels is 5' (donor) and 3' (acceptor) the average donor-
acceptor distance was found to be around 4 nm. If both donor and acceptor are attached to the 
5'-ends of the complementary oligonucleotides, the average donor-acceptor distance was 
found to be around 6 nm (table 3.1.). The calculated values are average distances because the 
flexible spacer groups between oligonucleotide and dye result in a variable distance of the 
fluorophores to each other. 
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Table 3.1. Calculated R0 values and average distances between donor and acceptor molecules. 
 
Donor Acceptor R0 [nm] Distance [nm] Labeling Positions
FO548/oligo1 FR646/oligo3 5.9 4.0 5' – 3' 
OB630/oligo5 OG670/oligo4 6.3 6.0 5' – 5' 
FO-C7/oligo1 FR642/oligo2 5.8 5.5 5' – 5' 
FO-C7/oligo1 FR642/oligo3 5.9 4.3 5' – 3' 
 R0 values were calculated by Jörg Enderlein, Forschungszentrum Jülich, Institute of Biological 
Information Processing I, 52425 Jülich, Germany. Calculations were carried out according to the 
method described in chapter 1.3. 
 
3.2.2. Competitive Hybridization Assays 
 
FO548/oligo1-FR646/oligo3 
Figure 3.23 shows a competitive hybridization assay in which FR646/oligo3 of constant 
concentration ([FR646/oligo3] = 1.7·10-7 mol/L) and various amounts of non-labeled oligo3 
were mixed, and a constant amount of FO548/oligo1 ([FO548/oligo1] = 1.7·10-7 mol/L) was 
added. The fluorescence of the donor increases with increasing fractions of oligo3. The 
acceptor is displaced by non-labeled oligonucleotide and energy transfer efficiency is 
reduced. In this case the decrease of the acceptor intensity is not visible due to the low 
fluorescence intensity of the acceptor. The plot of the ratio of the two peak intensities versus 
the concentration ratio of the non-labeled oligonucleotides to the acceptor shows the binding 
curve very well (fig. 3.23; left side). Saturation is reached at am about 3-fold excess of oligo3. 
Determination of analyte concentration is possible in the dynamic range from 4·10-8 mol/L to 
2·10-7 mol/L which was determined graphically. A negative control with oligo8 which neither 
hybridizes with FO548/oligo1 nor with FR646/oligo3 was performed for the purpose of 
comparison. The binding curve shows that in this case energy transfer is not affected at all 
(fig. 3.23; left side, red line). 
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Figure 3.23. Left side: Competitive immunoassay in which FR646/oligo3 of constant 
concentration ([FR646/oligo3] = 1.7·10-7 mol/L) was mixed with various 
amounts of non-labeled oligo3 and constant quantities of FO548/oligo1 
([FO548/oligo1] = 1.7·10-7 mol/L). λexc = 500 nm.  
 Right side: Plot of the ratio of the two peak intensities versus the 
concentration ratio of the non-labeled oligonucleotides and FO548/oligo1. 
 
OB630/oligo5-OG670/oligo4 
The effect of single mismatches in an oligonucleotide on the hybridization rate was examined 
via a competitive hybridization assay on the system OB630/oligo5-OG670/oligo4. The donor 
of constant concentration ([OB630/oligo5] = 1.67·10-7 mol/L) was mixed with the following 
non-labeled oligonucleotides: oligo3 (no mismatch), oligo6 (single mismatch), or oligo7 
(double mismatch). Constant quantities of acceptor ([OG670/oligo4] = 1.67·10-7 mol/L) were 
added. The binding curves are shown in figure 3.24. Oligo3 which is complementary to 
OG670/oligo4 shows the most efficient binding (fig. 3.24; black line). If one single mismatch 
is introduced into the center of the oligonucleotide (oligo6) binding is expected to be reduced. 
This effect is displayed in figure 2.24 (red line). Using oligo6 (single mismatch) the ratio 
I(642 nm)/I(674 nm) is reduced to 75% in comparison to oligo3. If a second mismatch next to 
the first one is introduced, this effect is enhanced (blue line). I(642 nm)/I(674 nm) drops to 
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25% compared to oligo3. Determination of the concentration of oligo3 is possible in the 
dynamic range from 8·10-8 mol/L to 5·10-7 mol/L which was determined graphically. 
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Figure 3.24. Competitive hybridization assays in which OB630/oligo5 (donor) of constant 
concentration ([OB630/oligo5] = 1.67·10-7 mol/L) was mixed with oligo3 (no 
mismatch), oligo6 (single mismatch), or oligo7 (double mismatch), and constant 
quantities of OG670/oligo4 (acceptor) ([OG670/oligo4] = 1.67·10-7 mol/L) were 
added. λexc = 600 nm. 
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3.2.3. Fluorescence in Situ Hybridization (FISH) 
A common method of introducing fluorophores into probe DNA is to use fluorescent bases. 
The reactive amino group attached to dUTP can be coupled to a wide variety of reactive 
fluorophores, including OSI esters (see figure 3.25.).  
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Figure 3.25. Scheme for the reaction of aminoallyl dUTP with the OSI ester of a fluorescent 
dye. 
 
In this work, FR661 and PB634 were conjugated to aminoallyl dUTP. The labeled dUTP was 
employed in PCR producing specific sequences of DNA (known as the probe) which were 
labeled with fluorescent molecules throughout their lengths. A mixture of probes specific for 
many regions along the length of one specific chromosome, in our case the mouse Y-
chromosome, was produced and applied in fluorescence in situ hybridization (FISH). 
 FISH is a highly versatile method based on the ability of DNA to hybridize to its 
complementary sequence [9]. First, the biological material has to be fixed to preserve 
morphology. Then, the double strands of DNA in both the probe DNA and the chromosome 
DNA have to denature so that they can hybridize to each other. This is done by heating the 
DNA (70 - 80 °C). After that, the probe is placed on a slide and a glass coverslip is placed on 
top. The slide is then placed in a 37 °C incubator for several hours for the probe to hybridize 
with the target chromosome. The probe DNA seeks out its target sequence on the specific 
chromosome and binds to it. The strands slowly reanneal. Then the slide is washed to remove 
any of the probe that did not bind to chromosomes. A differently colored fluorescent dye is 
added to the slide to stain all of the chromosomes so that they may then be viewed using a 
fluorescence microscope [10, 11].  
 Such an experiment was performed with a probe which contained aminoallyl dUTP. It 
is possible to clearly visualize under a fluorescence microscope that the probe labeled with 
PB634 has hybridized to the mouse Y-chromosome. Figure 3.26 shows the mouse metaphase 
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recorded with a b/w CCD camera. The chromosomes in figure 3.26 are miscolored, where the 
X-chromosomes are colored blue and the Y-chromosome is colored green. 
 
  
Figure 3.26. Mouse metaphase recorded with a b/w CCD camera. The chromosomes are 
painted in blue and the Y-chromosome is painted in green. 
 
In contrast to the above result, a FISH using DNA probes labeled with FR661 yielded no 
results, because the fluorescence of the DNA probes was too weak to be detected by 
fluorescence microscope. 
 
3.3. Conclusions 
Immunosystems 
In this work immunostudies were performed on the system HSA/anti-HSA. Binding studies 
were performed on the systems FO546/HSA-FR642/anti-HSA, FO548/HSA-FR646/anti-
HSA, and [Ru(bpy)2(mcbpy)]/HSA-FR662/anti-HSA. All of these systems worked properly 
and gave sigmoidal binding curves. The shape of the curve strongly depends on the DPRs of 
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the donor and acceptor conjugates, respectively. The influence of non-labeled anti-HSA on 
the fluorescence of donor labeled HSA is negligible. Free acceptor dye may have influence on 
the ratiometric plot, because on the one hand it can be excited by the light source and on the 
other hand it might bind non-covalently to HSA which enables non-desired energy transfer. 
The use of a ruthenium comlex with a large Stokes' shift as donor dye has the advantage that 
at the excitation wavelenght of 460 nm the acceptor is not excited by the light source.  
 Homogenous competitive immunoassays were shown using the systems FO546/HSA-
FR642/anti-HSA, FO548/HSA-FR646/anti-HSA. These systems can be used for the 
determination of HSA concentrations in the range of 2·10-9 - 2.5·10-7 mol/L. A larger 
concentration range could be obtained by further variations of the DPRs or by variation of the 
concentrations or ratios of donor and acceptor. It was proved that BSA has no influence on the 
immunosystem. 
 A cytometric measurement has been performed to show the applicability of the dyes in 
flow cytometry. The introduced systems can be used for the determination of HSA 
concentrations in the range of 0 - 120 µg/mL (1.5·10-7 - 1.8·10-8 mol/L). 
 
Hybridization Systems 
Hybridization binding studies were carried out on the systems FO548/oligo1-FR646/oligo3, 
oligo5/oligo4, FO546/oligo1-FR642/oligo2, and FO546/oligo1-FR642/oligo3. The Förster 
radii (R0) of the donor-acceptor pairs are all are around 6 nm. The average donor-acceptor 
distance was found to be around 4 nm if the position of the labels was 5' (donor) and 3' 
(acceptor), and 6 nm if both donor and acceptor were attached to the 5'-ends of the 
complementary oligonucleotides. 
 Competitive hybridization assays were performed on the systems FO548/oligo1-
FR646/oligo3 and OB630/oligo5-OG670/oligo4. The presented competitive assays enable 
determination of oligonucleotide concentrations in the range of 4·10-8 to 6·10-6 mol/L. In 
addition these measurements enable the distinction of oligonucleotides without, with a single, 
or with a double mismatch in their sequence. 
 Fluorescence in situ hybridization (FISH) was carried out using DNA probes labeled 
with PB634 and FR661, respectively. Good results were only achieved with PB634, because 
the fluorescence intensity of FR661 was too weak to be detected via fluorescence microscopy. 
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4. Experimental Part 
 
4.1. Materials and Methods 
4.1.1. Chemicals, Solvents, Proteins and Oligonucleotides 
All chemicals and solvents used were purchased from Acros (Geel, Belgium), Aldrich 
(Steinheim, Germany), Fluka (Buchs, Switzerland), Merck (Darmstadt, Germany) or Sigma 
(Steinheim, Germany). All chemicals were of analytical grade and were used as received. 
Anhydrous dichloromethane and DMF were prepared following standard procedures [1]. 
Water was doubly destilled. HSA and anti-HSA were obtained from Sigma. DNA 
oligonucleotide syntheses, phosphoramidite labeling, and molecular beacon synthesis were 
carried out by Metabion (Martinsried, Germany). The following sequences were used: oligo1: 
amino-5'-CCG GCA GCA AAA TGT-3', oligo2: amino-5'-ACA TTT TGC TGC CGG-3', 
oligo3: 5'-ACA TTT TGC TGC CGG-3'-amino, oligo4: 5'-CCG GCA GCA AAA TGT-3', 
oligo5: 5'-ACA TTT TGC TGC CGG-3', oligo6: 5'-ACA TTT TCC TGC CGG-3', oligo7: 5'-
ACA TTT ACC TGC CGG-3, oligo8: 5'-GGC CGT CGT TTT ACA. 
 Phosphate buffer (PBS) of pH 7.2, 100 mM: 25.79 g of Na2HPO4·12 H2O and 4.37 g 
of NaH2PO4·2 H2O are dissolved in 1 L of doubly destilled water. Bicarbonate buffer 
(BCBS) of pH 9, 50 mM: 2.1 g of NaHCO3 are dissolved in 500 mL of doubly destilled 
water. Triethylammonium acetate (TEAA) of pH 7.1, 0.1 M: 13.8 mL of triethylamine and 
5.76 mL of acetic acid are mixed and diluted to 1 L with water. The buffers are adjusted to the 
corresponding pH value with 1 N HCl and 1 N NaOH, respectively. pH measurements were 
performed with a WTW pH 196 pH meter with temperature compensation. 
 
4.1.2. Chromatography 
For analytical thin-layer chromatography RP-18 (TLC) F254s aluminum sheets and silica gel 
60 F254 aluminum sheets (thickness 0.2 mm each) from Merck (Darmstadt, Germany) were 
used. Column chromatography was carried out using silica gel 60 (40-63 µm) as the 
stationary phase for non-polar substances and silica gel 60 RP-18 (40-63 µm) or LiChroprep 
RP-18 (40-63 µm) as the stationary phase for polar substances (all from Merck). HPLC was 
performed on a Knauer HPLC 64 apparatus. A Hibar pre-packed column RT (250 x 4 mm) 
packed with LiChrosorb RP 18 (10 µm) was used as the stationary phase.  
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Labeled protein was separated from unlabeled dye by gel permeation chromatography using 
Sephadex G-25 from Sigma as the stationary phase (2 x 12 cm column) and a 22 mM PBS of 
pH 7.2 as the eluent. 
 
4.1.3. Melting Points 
Melting points (m.p.) were measured with a melting point apparatus "Dr. Tottoli" from Büchi. 
They were determined in open capillary tubes and are not corrected. 
 
4.1.4. Spectra 
1H-NMR spectra were recorded with a 250 MHz PFT-NMR spectrometer (AC 250 from 
Bruker) or a 400 MHz PFT-NMR spectrometer (ARX 400 from Bruker). The internal or 
external standard was tetramethylsilan (TMS) or the solvent. 31P-NMR spectra were recorded 
with a 400 MHz PFT-NMR spectrometer (ARX 400 from Bruker) with H3PO4 as external 
standard. The chemical shifts are given in ppm. The following abbreviations were used to 
describe the signals: s = singlet, d = doublet, dd = doublet of doublets, dt = doublet of triplets, 
t = triplet, q = quartet, quin = quintet, m = multiplet, b = broad. Mass spectra were recorded 
with a Finnigan MAT 95 (fast-atom bombardment, FAB) and with a Finnigan SSQ 2000 
(electro-spray ionization, ESI). 
Absorption spectra were taken with a Cary 50 Bio UV-Visible Spectrophotometer 
from Varian. Emission spectra were recorded with a luminescence spectrometer Aminco 
Bowman (Series 2) from SLM with a standard 150 W xenon lamp as the excitation source. 
 
4.2. Synthesis and Purification of the Dyes 
4.2.1. FO544 
4.2.1.1. 1-(3-Ethoxycarbonyl-propyl)-2,3,3-trimethyl-3H-indolium Bromide 
 
N N
(CH2)3
COOEtBr
Br (CH2)3 COOEt+
C11H13N
159.23
C6H11BrO2
195.06
C17H24BrNO2
354.29
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5.00 mL (31.1 mmol) of 2,3,3-trimethyl-3H-indole and 4.45 mL (31.1 mmol) of ethyl-4-
bromobutyrate are heated under stirring in a pressure tube to 110 °C under argon for 16 h. 
After cooling to room temperature the solid is dissolved in water and diethylether is added. 
The aqueous phase is extracted with diethylether. The aqueous phase is collected and water is 
removed on a rotary evaporator. The amorphous red residue is dried in a desiccator over P2O5. 
The residue is washed twice with 20 mL of acetone and a white powder remains. 
 
Yield: 4.90 g, (13.8 mmol, 44%), white powder, C17H24BrNO2 (354.29 g/mol). 
1H-NMR (DMSO, TMS external): δ 8.00 (m, 1H), 7.83 (m, 1H), 7.63 (m, 2H), 4.46 (t, 2H), 
4.02 (q, b 2H), 2.83 (s, 3H), 2.08 (m, 2H), 1.53 (s, 6H), 1.14 (t, 3H). 
 
4.2.1.2. 1-[2-(Diethoxyphosphoryl)-ethyl]-2,3,3-trimethyl-3H-indolium Bromide 
 
1.00 mL (991 mg, 6,22 mmol) of 2,3,3-trimethyl-3H-indole and 1.00 mL (1.35 g, 5.50 mmol) 
of diethyl(2-bromoethyl)phosphonate are dissolved in a mixture of 5 mL of water and 3 mL of 
ethanol. The solution is refluxed for 30 h. After cooling to room temperature the solvent is 
removed under reduced pressure. The residue is dissolved in water and extracted with 
diethylether. The aqueous phase is collected and water is removed on a rotary evaporator. The 
amorphous product is dried in a desiccator over P2O5 and then triturated with ethylacetate 
until the faintly purple product crystallizes. 
 
Yield: 660 mg (1.63 mmol, 30%), faintly purple powder, C17H27BrNO3P (404.29 g/mol). 
m.p.: 108 °C, Rf (silica gel RP-18, methanol): 0.67. 
1H-NMR (D2O, TMS external): δ 7.69-7.40 (m, 4H), 4.66 (m, 2H), 3.94 (m, 4H), 2.63 (s, 3H), 
2.55 (m, 2H), 1.43 (s, 6H), 1.06 (t, 6H). (Singlet for 2-methyl does not appear in D2O.) 
FAB-MS: m/e (M+, cation) for C17H27NO3P, calculated 324.4, found 324.3. 
 
N N
(CH2)2
PO(OEt)2Br
diethyl(2-bromoethyl)
phosphonate
C11H13N
159.23
C17H27BrNO3P
404.28
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4.2.1.3. FO544-Acid 
 
1.20 g (2.96 mmol) of 1-[2-(diethoxyphosphoryl)ethyl]-2,3,3-trimethyl-3H-indolium bromide 
and 1.05 g (2.96 mmol) of 1-(3-ethoxycarbonyl-propyl)-2,3,3-trimethyl-3H-indolium bromide 
are heated in 12 mL of pyridine to 95 °C until the educts dissolve. 400 µL (3.64 mmol) of 
1,1,1-trimethoxymethane are added and the solution is kept at 95 °C for 15 h. After cooling to 
room temperature the purple solution is slowly dropped into 150 mL of diethylether whereas 
the purple product precipitates. The suspension is allowed to stand for 30 minutes. 
Diethylether is decanted. The precipitate is dissolved in 10 mL of methanol. 10 mL of water 
and 276 mg of K2CO3 are added and the solution is refluxed for 5 h. The solvent is removed 
on a rotary evaporator. The raw product is purified by column chromatography using silica 
gel 60 RP-18 (40-63 µm) as the stationary phase and a methanol/water mixture (50:50 v/v) as 
the eluent. 
 
Yield: 118 mg (0.21 mmol, 7%), purple powder, C31H39N2O5P (550.63 g/mol). 
Rf (silica gel RP-18, methanol:water 75:25 v/v): 0.58. 
1H-NMR (d4-methanol): δ 7.88 (t, 1H), 6.87 (m, 2H), 6.80-6.75 (m, 4H),6.63, (m, 2H), 5.84 
(dd, 2H), 3.65 (m, 2H), 3.54 (t, 2H), 3.30 (quin, 2H), 1.72 (t, 2H), 1.49-1.33 (m, 4H), 1.10 (s, 
6H), 1.09 (s, 6H), 1.60 (t, 3H). 
 
4.2.1.4. FO544-OSI Ester 
N
(CH2)2
PO(OEt)2
Br
N
(CH2)3
COOH
+ +    HC(OMe)3
C17H27BrNO3P
404.28
pyridine
C4H10O3
 120.15
Br
(CH2)3
NN
(CH2)2
PO(O)(OEt)COOH
C15H20BrNO2
326.23
C31H39N2O5P
550.63
NN
(CH2)2
PO(O)(OEt)
(CH2)3
COOH
NHS/DCC
acetonitrile
CO
O
N OO
NN
(CH2)2
PO(O)(OEt)
(CH2)3
C31H39N2O5P
550.63
C35H42N3O7P
647.71
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28.5 mg (51.7 µmol) of FO544-acid, 11.9 mg (103 µmol) of NHS and 21.4 mg (103 µmol) of 
DCC are dissolved in 1 mL of dry acetonitrile. The solution is stirred at room temperature for 
20 h. The solvent is removed on a rotary evaporator and the raw product is washed with 
diethylether. The OSI ester is used without further purification. 
 
Yield: 23.0 mg (41.8 µmol, 81%), purple powder, C35H42N3O7P (647.71 g/mol). 
Rf (silica gel RP-18, methanol:water 75:25 v/v): 0.42. 
 
4.2.2. FO545 
4.2.2.1. 1-(5-Carboxypentyl)-2,3,3-trimethyl-3H-indolium Bromide 
 
1.00 mL (991 mg, 6.22 mmol) of freshly distilled 2,3,3-trimethyl-3H-indole and 1.23 g (6.22 
mmol) of 6-bromohexanoic acid are heated to 110 °C under argon for 18 h. After cooling to 
room temperature the solid is dissolved in water and extracted with ether. The aqueous phase 
is collected and water is removed on a rotary evaporator. The product is dried in a desiccator 
over P2O5. 
 
Yield: 1.61 g (4.54 mmol, 73%), faintly purple powder, C17H24BrNO2 (354.29 g/mol). 
Rf (silica gel RP-18, methanol): 0.61. 
1H-NMR (DMSO, TMS external): δ 7.96 (m, 1H), 7.84 (m, 1H), 7.62 (m, 2H), 4.44 (t, 2H), 
2.83 (s, 3H), 2.22 (t, 2H), 1.83 (m, 2H), 1.55 (m, 2H), 1.52 (s, 6H), 1.41 (m, 2H). 
 
N N
(CH2)5
COOHBr
6-bromohexanoic acid
C11H13N
159.23
C17H24BrNO2
354.29
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4.2.2.2. FO545-Acid 
 
1.20 g (2.96 mmol) of 1-[2-(diethoxyphosphoryl)ethyl]-2,3,3-trimethyl-3H-indolium bromide 
and 1.05 g (2.96 mmol) of 1-(5-carboxypentyl)-2,3,3-trimethyl-3H-indolium bromide are 
heated in 12 mL of pyridine to 95 °C until the educts dissolve. 400 µL (3.64 mmol) of 1,1,1-
trimethoxymethane are added and the solution is kept at 90 °C for 18 h. After cooling to room 
temperature diethylether is added until the purple product precipitates. The raw product is 
purified by two steps of column chromatography. In the first step silica gel 60 RP-18 (40-63 
µm) was used as the stationary phase and a methanol/water mixture (50:50 v/v) containing 
0.1% NH3 as the eluent. Second LiChroprep RP-18 (40-63 µm) was used as the stationary 
phase and a methanol/water mixture (80:20 v/v) as the eluent. 
 
Yield: 115.0 mg (0.20 mmol, 7%), purple powder, C33H43N2O5P (578.69 g/mol). 
Rf (silica gel RP-18, methanol:water 7:3 v/v): 0.26. 
1H-NMR (d4-methanol, TMS): δ 8.54 (t, 1H), 7.52 (m, 2H), 7.47-7.28 (m, 6H), 6.50 (d, 1H), 
6.46 (d, 1H), 4.30 (m, 2H), 4.16 (t, 2H), 3.97 (quin, 2H), 2.31 (t, 2H), 1.98 (m, 2H), 1.86 (t, 
2H), 1.77 (s, 6H), 1.76 (s, 6H), 1.70 (m, 2H), 1.52 (m, 2H), 1.27 (t, 3H). 31P{1H}-NMR (d4-
methanol, H3PO4 external): δ 21.80. 
 
4.2.2.3. FO545-OSI Ester 
NN
(CH2)2
PO(O)(OEt)
(CH2)5
COOH
C33H43N2O5P
578.69
N
(CH2)2
PO(OEt)2
Br
N
(CH2)5
COOH
+ +    HC(OMe)3
C17H27BrNO3P
404.28
C17H24BrNO2
354.29
pyridine
C4H10O3
 120.15
Br
NN
(CH2)2
PO(O)(OEt)
(CH2)5
CO
O
N OO
C37H46N3O7P
675.76
NN
(CH2)2
PO(O)(OEt)
(CH2)5
COOH
C33H43N2O5P
578.69
NHS/DCC
acetonitrile
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30.0 mg (51.8 µmol) of FO545-acid, 11.9 mg (104 µmol) of NHS and 21.4 mg (104 µmol) of 
DCC are dissolved in 1 mL of dry acetonitrile. The solution is stirred at room temperature for 
20 h. The solvent is removed on a rotary evaporator and the raw product is purified by column 
chromatography using LiChroprep RP-18 (40-63 µm) as the stationary phase and a 
water/acetone mixture (40:60 v/v) as the eluent. 
 
Yield: 24.0 mg (35.5 µmol, 69%), purple powder, C37H46N3O7P (675.76 g/mol). 
Rf (silica gel RP-18, methanol:water 70:30 v/v): 0.16. 
1H-NMR (d4-methanol, TMS): δ 8.54 (t, 1H), 7.53 (m, 2H), 7.46-7.28 (m, 6H), 6.48 (m, 2H), 
4.30 (m, 2H), 4.16 (t, 2H), 3.97 (quin, 2H), 2.66 (s, 4H), 2.02 (m, 2H), 1.87 (t, 2H), 1.79 (m, 
2H), 1.77 (s, 6H), 1.76 (s, 6H), 1.67 (m, 2H), 1.59 (m, 2H), 1.26 (t, 3H). 
 
4.2.3. FO546 
4.2.3.1. 1-(7-Carboxyheptyl)-2,3,3-trimethyl-3H-indolium Bromide 
 
1.00 mL (6.23 mmol) of 2,3,3-trimethyl-3H-indole and 1.39 g (6.23 mmol) of 8-
bromooctanoic acid are heated under stirring in a pressure tube to 110 °C under argon for 16 
h. After cooling to room temperature the solid is dissolved in 40 mL of water and 20 mL 
diethylether are added. The aqueous phase is extracted five times with 20 mL of diethylether. 
The aqueous phase is collected and the water is removed on a rotary evaporator. The 
amorphous red residue is dried in a desiccator over P2O5. 
 
Yield: 2.12 g (5.54 mmol, 89%), amorphous brown solid, C19H28BrNO2 (382.34 g/mol). 
1H-NMR (DMSO, TMS external): δ 7.95 (m, 1H), 7.82 (m, 1H), 7.62 (m, 2H), 4.44 (t, 2H), 
2.83 (s, 3H), 2.18 (t, 2H), 1.81 (m, 2H), 1.52 (s, 6H), 1.48-1.26 (m, 8H). 
 
N N
(CH2)7
COOHBr
Br (CH2)7 COOH+
C11H13N
159.23
C8H15BrO2
223.11
C19H28BrNO2
382.34
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4.2.3.2. FO546-Acid 
 
972 mg (2.40 mmol) of 1-[2-(diethoxyphosphoryl)ethyl]-2,3,3-trimethyl-3H-indolium 
bromide and 915 mg (2.40 mmol) of 1-(7-carboxyheptyl)-2,3,3-trimethyl-3H-indolium 
bromide are heated in 10 mL of pyridine to 90 °C until the educts dissolve. 324 µL (2.94 
mmol) of 1,1,1-trimethoxymethane are added and the solution is kept at 90 °C for 18 h. After 
cooling to room temperature the purple solution is slowly dropped into 150 mL of 
diethylether whereas the purple product precipitates. The suspension is allowed to stand for 
30 minutes. Diethylether is decanted. The precipitate is dissolved in 10 mL of methanol. 10 
mL of water and 276 mg of K2CO3 are added and the solution is refluxed for 20 h. The 
solvent is removed on a rotary evaporator. The raw product is purified by column 
chromatography using silica gel 60 RP-18 (40-63 µm) as the stationary phase and a 
methanol/water mixture (50:50 v/v) as the eluent. 
 
Yield: 93.0 mg (0.15 mmol, 6%), purple powder, C35H47N2O5P (606.74 g/mol). 
Rf (silica gel RP-18, methanol:water 7:3 v/v): 0.36. 
1H-NMR (d4-methanol, TMS): δ 8.54 (t, 1H), 7.53 (m, 2H), 7.46-7.28 (m, 6H), 6.49 (t, 2H), 
4.31 (m, 2H), 4.16 (t, 2H), 3.97 (quin, 2H), 2.24 (t, 2H), 2.02 (m, 2H), 1.84 (m, 2H), 1.76 (s, 
12H), 1.59 (m, 2H), 1.44-1.32 (m, 6H), 1.26 (t, 3H). 
 
4.2.3.3. FO546-OSI Ester 
N
(CH2)2
PO(OEt)2
Br
N
(CH2)7
COOH
+ +    HC(OMe)3
C17H27BrNO3P
404.28
pyridine
C4H10O3
 120.15
Br
C19H28BrNO2
382.34
(CH2)7
NN
(CH2)2
PO(O)(OEt)COOH
C35H47N2O5P
606.74
NN
(CH2)2
PO(O)(OEt)
(CH2)7
CO
O
N OO
NN
(CH2)2
PO(O)(OEt)
(CH2)7
COOH
NHS/DCC
acetonitrile
C35H47N2O5P
606.74
C39H50N3O7P
703.82
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150.0 mg (247.2 µmol) of FO546-acid, 42.6 mg (372 µmol) of NHS and 76.5 mg (372 µmol) 
of DCC are dissolved in 1 mL of dry acetonitrile. The solution is stirred at room temperature 
for 20 h. The solvent is removed on a rotary evaporator and the raw product is purified by 
column chromatography using LiChroprep RP-18 (40-63 µm) as the stationary phase and a 
water/acetone mixture (50:50 v/v) as the eluent. 
 
Yield: 69.0 mg (96.6 µmol, 39%), purple powder, C39H50N3O7P (703.82 g/mol). 
Rf (silica gel RP-18, methanol:water 7:3 v/v): 0.08. 
1H-NMR (d4-methanol, TMS): δ 8.54 (t, 1H), 7.53 (m, 2H), 7.47-7.28 (m, 6H), 6.49 (dd, 2H), 
4.30 (m, 2H), 4.17 (t, 2H), 3.97 (quin, 2H), 2.77 (s, 4H), 2.61 (t, 2H), 2.01 (m, 2H), 1.86 (m, 
2H), 1.76 (s, 6H), 1.75 (s, 6H), 1.72 (m, 2H), 1.49-1.40 (m, 6H), 1.27 (t, 3H). 
 
4.2.4. FO548 
4.2.4.1. 4-Hydrazino-benzenesulfonic acid 
(b) Na2SO3/HCl
(a) NaNO2/H2SO4
NH2
SO3H
NHNH2
SO3H
C6H7NO3S
173.19
C6H8N2O3S
188.20  
 
To a suspension of 104 g (0.60 mol) of 4-aminobenzenesulfonic acid in 400 mL of hot water 
33 g of sodium carbonate are added. The solution is cooled to 5° C and 70 g of concentrated 
sulfuric acid is added slowly under rapid stirring. Then a solution of 42 g of sodium nitrite in 
100 mL of water is added under cooling. The light yellow diazonium precipitate is filtered 
and washed with water. The wet diazonium compound is added to a stirred, cold solution (5° 
C) of 170 g of sodium sulfite in 500 mL of water. The solution which turns orange, is stirred 
under cooling for one hour, and then heated to reflux. Finally 400 mL of concentrated 
hydrochloric acid are added. First, the solution turns yellow, later the product precipitates as a 
white solid. For complete decoloration, 1-2 g of powdered zinc are added. The reaction 
mixture is cooled over night. The precipitate is filtered, washed with water and dried in an 
oven at 100 °C [2, 3]. 
 
Yield: 96 g (85%), white powder, C6H8N2O3S (188.20 g/mol). 
m.p.: > 250 °C (Lit.: 285 °C), Rf (RP-18, water:methanol 2:1 v/v): 0,95. 
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1H-NMR (d6-DMSO, TMS external): δ 10.00-9.70 (b, 2H), 8.30-8.20 (b, 1H), 7.50 (d, 2H), 
6.80 (d, 2H). 
 
4.2.4.2. Potassium 2,3,3-Trimethyl-3H-indole-5-sulfonate 
2.28 g (12.1 mmol) of 4-hydrazinobenzenesulfonic acid and 2.3 mL (21.9 mmol) of 3-methyl-
2-butanone are suspended in 15 mL of acetic acid and stirred at room temperature for one 
hour. Then the mixture is refluxed for 3 h. After cooling to room temperature, the solution is 
triturated with ether until the 2,3,3-trimethyl-3H-5-indolesulfonic acid crystallizes. The pink 
precipitate is filtered, washed with ether and then dissolved in methanol. To this solution a 
saturated solution of potassium hydroxide in 2-propanol is added until the precipitation of the 
yellow product is completed. The precipitate is filtered, washed with diethylether, and dried in 
a desiccator over P2O5 [3, 4]. 
 
Yield: 1.88 g (6.77 mmol, 56%) light-orange powder, C11H12KNO3S (277.37 g/mol). 
m.p.: 246-250 °C (decomp.), Rf (RP-18, methanol:water 1:1 v/v): 0.82. 
1H-NMR (d6-DMSO, TMS external): δ 7.70 (s, 1H), 7.60 (d, 1H), 7.35 (d, 1H), 2.30 (s, 3H), 
1.30 (s, 6H). 
 
4.2.4.3. 1-(5-Carboxypentyl)-2,3,3-trimethyl-3H-5-indoliumsulfonate 
C11H12KNO3S
277.38
N
KO3S 6-bromohexanoic acid/
1,2-dichlorbenzene
N
O3S
(CH2)5
COOH
C17H23NO5S
353.43  
C6H8N2O3S
SO3H
NH
NH2
(a) 3-methyl-2-butanone/acetic acid
(b) KOH/2-propanol
N
KO3S
180.20
C11H12KNO3S
277.38
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3.18 g (11.0 mmol) of potassium 2,3,3-trimethyl-3H-5-indolesulfonate and 2.58 g (13.0 
mmol) of 6-bromohexanoic acid are refluxed in 30 mL of 1,2-dichlorbenzene for 12 h. After 
cooling to room temperature the solvent is decanted. The pink precipitate is suspended in a 2-
propanol/diethylether mixture (1:1 v/v), filtered, washed with diethylether and chloroform and 
dried in a desiccator over P2O5 [3, 4]. 
 
Yield: 3.82 g (10.8 mmol, 94%), pink powder, C17H23NO5S (353.43 g/mol). 
m.p.: 135 °C (decomp.), Rf (RP-18, methanol:water 1:1 v/v): 0.79. 
1H-NMR (D2O, TMS external): δ 8.00 (s, 1H), 7.89 (d, 1H), 7.77 (d, 1H), 4.38 (t, 2H), 2.25 (t, 
2H), 1.86 (m, 2H), 1.48 (s, 6H), 1.59-1.29 (m, 4H) (Singlet for 2-methyl does not appear in 
D2O). 
FAB-MS: m/e (M+H+, cation) for C17H24NO5S, calculated 354.1, found 354.0. 
 
4.2.4.4. FO548-Acid 
 
300 mg (0.74 mmol) of 1-[2-(diethoxyphosphoryl)ethyl]-2,3,3-trimethyl-3H-indolium 
bromide and 261 mg (0.74 mmol) of 1-(5-carboxypentyl)-2,3,3-trimethyl-3H-5-
indoliumsulfonate are dissolved in 3 mL of pyridine. 100 µL (0.91 mmol) of 1,1,1-
trimethoxymethane are added and the solution is heated to 90 °C for 4h. After cooling to 
room temperature 50 mL of ether are added, and the purple precipitate is filtered. The raw 
product is purified by column chromatography using silica gel 60 RP-18 (40-63 µm) as the 
stationary phase and a methanol/water mixture (50:50 v/v) as the eluent.  
 
Yield: 44.0 mg (66.8 µmol, 9%), purple powder, C33H43N2O8PS (658.75 g/mol). 
Rf (silica gel RP-18, methanol:water 7:3 v/v): 0.81. 
1H-NMR (d4-methanol, TMS): δ 8.56 (t, 1H), 7.91 (m, 2H), 7.55 (m, 2H), 7.45 (m, 2H), 7.38 
(d, 1H), 6.58 (d, 1H), 6.47 (d, 1H), 4.34 (m, 2H), 4.16 (t, 2H), 3.99 (quin, 2H), 2.27 (t, 2H), 
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2.04 (m, 2H), 1.86 (t, 2H), 1.79 (s, 6H), 1.78 (s, 6H), 1.68 (m, 2H), 1.52 (m, 2H), 1.27 (t, 3H). 
31P{1H}-NMR (d4-methanol, H3PO4 external): δ 20.40. 
ESI-MS: m/e (M-H+, anion) for C33H42N2O8PS, calculated 657.2, found 657.0. 
 
4.2.4.5. FO548-OSI Ester  
 
30 mg (45.6 µmol) of FO548-acid, 7.8 mg (68.1 µmol) of NHS, and 14.1 mg (68.1 µmol) of 
DCC are dissolved in 1 mL of dry DMSO. The solution is stirred at room temperature for 20 
h. 5 mL of diethylether are added, and the purple precipitate is purified by column 
chromatography using LiChroprep RP-18 (40-63 µm) as the stationary phase and a 
water/acetonitrile mixture (75:25 v/v) as the eluent. 
 
Yield: 16.0 mg (21.1 µmol, 46%), purple powder, C37H46N3O10PS (755.82 g/mol). 
Rf (silica gel RP-18, water:acetonitrile 3:1 v/v): 0.28. 
1H-NMR (d4-methanol, TMS): δ 8.56 (t, 1H), 7.89 (m, 2H), 7.56 (d, 1H), 7.45 (m, 2H), 7.37 
(m, 2H), 6.58 (d, 1H), 6.47 (d, 1H), 4.34 (m, 2H), 4.16 (t, 2H), 3.97 (quin, 2H), 2.67 (s, 4H), 
2.22 (t, 2H), 2.04 (m, 2H), 1.85 (t, 2H), 1.79 (s, 6H), 1.78 (s, 6H), 1.70 (quin, 2H), 1.50 (quin, 
2H), 1.27 (t, 3H). 
ESI-MS: m/e (M-H+, anion) for C37H45N3O10PS, calculated 754.3, found 754.0. 
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4.2.5. FR642 
4.2.5.1. FR642-Acid 
 
671 mg (1.66 mmol) of 1-[2-(diethoxyphosphoryl)ethyl]-2,3,3-trimethyl-3H-indolium 
bromide and 588 mg (1,66 mmol) of 1-(5-carboxypentyl)-2,3,3-trimethyl-3H-indolium 
bromide are heated in 7 mL of pyridine to 95 °C until the educts dissolve. 330 µL (1.98 
mmol) of 1,1,3,3-tetramethoxypropane are added and the solution is kept at 95 °C for 18 h. 
After cooling to room temperature diethylether is added until the blue product precipitates. 
The raw product is purified by two steps of column chromatography. In the first step silica gel 
60 RP-18 (40-63 µm) is used as the stationary phase and a methanol/water mixture (50:50 
v/v) containing 0.1% NH3 as the eluent. Second LiChroprep RP-18 (40-63 µm) is used as the 
stationary phase and a methanol/water mixture (70:30 v/v) as the eluent .  
 
Yield: 51.0 mg (84.3µmol, 5%), blue powder, C35H45N2O5P (604.73 g/mol). 
Rf (silica gel RP-18, methanol:water 80:20 v/v): 0.33. 
1H-NMR (d4-methanol, TMS): δ 8.23 (dt, 2H), 7.48 (t, 2H), 7.40 (t, 2H), 7.39-7.22 (m, 4H), 
6.65 (t, 1H), 6.32 (dd, 2H), 4.25 (m, 2H), 4.12 (t, 2H), 3.97 (quin, 2H), 2.30 (t, 2H), 1.98 (m, 
2H), 1.83 (t, 2H), 1.72 (s, 6H), 1.71 (s, 6H), 1.69 (m, 2H), 1.49 (m, 2H), 1.28 (t, 3H). 
31P{1H}-NMR (d4-methanol, H3PO4 external): δ 20.62. 
 
4.2.5.2. FR642-OSI Ester 
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30.0 mg (42.8 µmol) of FR642-acid, 9.8 mg (85.6 µmol) of NHS and 17.7 mg (85.6 µmol) of 
DCC are dissolved in 1 mL of dry acetonitrile. The solution is stirred at room temperature for 
20 h. The solvent is removed on a rotary evaporator and the raw product is purified by column 
chromatography using LiChroprep RP-18 (40-63 µm) as the stationary phase and a 
water/acetone mixture (40:60 v/v) as the eluent. 
 
Yield: 23.0 mg (32.7 µmol, 76%), blue powder, C39H48N3O7P (701.80 g/mol). 
Rf (silica gel RP-18, methanol:water 70:30 v/v): 0.08. 
1H-NMR (d4-methanol, TMS): δ 8.23 (dt, 2H), 7.47 (t, 2H), 7.40 (m, 2H), 7.39-7.23 (m, 4H), 
6.65 (t, 1H), 6.34 (dd, 2H), 4.25 (m, 2H), 4.12 (t, 2H), 3.97 (quin, 2H), 2.84 (s, 4H), 1.98 (m, 
2H), 1.82 (m, 4H), 1.72 (s, 6H), 1.71 (s, 6H), 1.59 (m, 4H), 1.27 (t, 3H). 
 
4.2.6. FR646 
4.2.6.1. FR646-Acid  
 
300 mg (0.74 mmol) of 1-[2-(diethoxyphosphoryl)ethyl]-2,3,3-trimethyl-3H-indolium 
bromide and 261 mg (0.74 mmol) of 1-(5-carboxypentyl)-2,3,3-trimethyl-3H-5-
indoliumsulfonate are dissolved in 3 mL of pyridine. 150 µL (0.90 mmol) of 1,1,3,3-
tetramethoxyproane are added and the solution is heated to 90 °C for 4h. After cooling to 
room temperature, 50 mL of diethylether are added, and the blue precipitate is filtered. The 
raw product is purified by column chromatography using silica gel 60 RP-18 (40-63 µm) as 
the stationary phase and a methanol/water mixture (50:50 v/v) as the eluent.  
 
Yield: 46.0 mg (67.2 µmol, 9%), blue powder, C35H45N2O8PS (684.78 g/mol). 
Rf (silica gel RP-18, methanol:water 6:4 v/v): 0.69. 
1H-NMR (d4-methanol, TMS): δ 8.30 (t, 1H), 8.25 (t, 2H), 7.86 (m, 2H), 7.51 (d, 1H), 7.42 
(m, 2H), 7.30 (t, 2H), 6.68 (t, 1H), 6.43 (d, 1H), 6.28 (d, 1H), 4.30 (m, 2H), 4.09 (t, 2H), 3.97 
(quin, 2H), 2.25 (t, 2H), 2.01 (m, 2H), 1.81 (t, 2H), 1.74 (s, 6H), 1.73 (s, 6H), 1.69 (t, 2H), 
1.48 (m, 2H), 1.28 (t, 3H). 31P{1H}-NMR (d4-methanol, H3PO4 external): δ 20.42. 
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ESI-MS: m/e (M-H+, anion) for C33H42N2O8PS, calculated 683.3, found 683.0. 
 
4.2.6.2. FR646-OSI Ester 
 
31.2 mg (45.6 µmol) of FR646-acid, 7.8 mg (68.1 µmol) of NHS, and 14.1 mg (68.1 µmol) of 
DCC are dissolved in 1 mL of dry DMSO. The solution is stirred at room temperature for 20 
h. 5 mL of ether are added, and the blue precipitate is purified by column chromatography 
using LiChroprep RP-18 (40-63 µm) as the stationary phase and a water/acetonitrile mixture 
(3:1 v/v) as the eluent. 
 
Yield: 12.9 mg (17.1 µmol, 37%), blue powder, C39H48N3O10PS (781.86 g/mol). 
Rf (silica gel RP-18, water:acetonitrile 3:1 v/v): 0.18. 
1H-NMR (d4-methanol, TMS): δ 8.30 (t, 1H), 8.25(t, 2H), 7.86 (m, 2H), 7.52 (d, 1H), 7.42 (m, 
2H), 7.30 (t, 2H), 6.68 (t, 1H), 6.42 (m, 1H), 6.28 (d, 1H), 4.30 (m, 2H), 4.09 (t, 2H), 3.97 
(quin, 2H), 2.67(s, 4H), 1.98 (m, 2H), 1.83 (m, 2H), 1.74 (s, 6H), 1.73 (s, 6H), 1.72-1.47 (m, 
6H), 1.28 (t, 3H). 
 
4.2.7. FR626 [5] 
4.2.7.1. 1-Ethyl-2,3,3-trimethyl-3H-5-indoliumsulfonate 
 
N
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1.1 g (4.0 mmol) of potassium 2,3,3-trimethyl-3H-5-indolesulfonate are suspended in 10 mL 
of ethyl iodide. The reaction mixture is heated to 110 °C for 24 h in a sealed tube. After 
cooling to room temperature excess ethyl iodide is decanted and the residue is suspended in 
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10 mL of acetone and stirred at room temperature for 20 min. The solution is filtered, the 
residue is washed with acetone and diethylether and dried in a desiccator over P2O5 [4]. 
 
Yield: 320 mg (1.2 mmol, 30%), dark violet powder, C13H17NO3S (267.34 g/mol). 
1H-NMR: (d6-DMSO, TMS external): δ 8.01 (s, 1H), 7.90 (d, 1H), 7.83 (d, 1H), 2.23 (q, 2H), 
2.81 (s, 3H), 1.53 (s, 6H), 1.41 (t, 3H). 
 
4.2.7.2. 3-Butoxy-4-(1-ethyl-3,3-dimethyl-1,3-dihydro-5-sulfonyl-indol-2-ylidenemethyl)-
cyclobut-3-ene-1,2-dione 
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500 mg (1.87 mmol) of 1-ethyl-2,3,3-trimethyl-3H-5-indoliumsulfonate and 500 µL (2.3 
mmol) of 3,4-dibutoxy-3-cyclobutene-1,2-dione are dissolved in 20 mL of ethanol and 1 mL 
of triethylamine. The reaction mixture is refluxed at for 3 h. After cooling to room 
temperature, the solvent is removed under reduced pressure and the raw product is dissolved 
in a low amount of water and extracted three times with chloroform. Water is removed and 
the resulting brown-yellow product is pure enough for further reactions. 
 
Yield: 380 mg (0.9 mmol, 48%), brown-yellow powder, C21H25NO6S (419.49 g/mol). 
4. Experimental Part  96 
4.2.7.3. FR626-Acid 
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380 mg (0.9 mmol) of 3-butoxy-4-(1-ethyl-3,3-dimethyl-1,3-dihydro-5-sulfonyl-indol-2-
ylidenemethyl)-cyclobut-3-ene-1,2-dione and 350 mg (1 mmol) of 1-(5-carboxypentyl)-2,3,3-
trimethyl-3H-indolium bromide are dissolved in 20 mL of a 1-butanol/toluene mixture (1:1, 
v/v) and are refluxed for 14 h. The solvent is removed and the dye is purified by column 
chromatography using silica gel 60 RP-18 (40-63 µm) as the stationary phase and a 
methanol/water mixture (40:60, v/v) as the eluent. 
 
Yield: 75 mg (0.12 mmol, 12%), blue powder, C34H38N2O7S (618.74 g/mol). 
Rf (methanol/water 5:5): 0.47.  
1H-NMR: (d4-methanol, TMS external): δ 7.84 (m, 2H), 7.64-7.03 (m, 5H), 6.03 (s, 1H), 5.96 
(s, 1H), 4.17 (m, 4H), 2.27-2.17 (m, 5H), 1.76 (s, 12H), 1.65 (m, 2H), 1.40 (m, 2H), 1.30 (m, 
2H). 
ESI-MS: m/e (M-H+, anion) for C34H38N2O7S, calculated 617.4, found 617.3. 
 
4.2.7.4. FR626-OSI Ester 
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60 mg (97 µmol) of FR626-acid, 17 mg (145 µmol) of NHS and 30 mg (145 µmol) of DCC 
are dissolved in 1 mL of dry acetonitrile. The solution is stirred at room temperature for 20 h. 
The solvent is removed on a rotary evaporator and the raw product is washed with 
diethylether. The OSI ester is used without further purification. 
 
Yield: 51 mg (68 µmol, 70%), blue powder, C38H41N3O9S (715.82 g/mol). 
4.2.8. FR661 
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4.2.7.1. 6-(4-Methyl-1-quinolinium)hexanoic Acid Bromide 
 
5 g (35 mmol, 4.62 mL) of 4-methylquinoline and 6.81 g (35 mmol) of 6-bromohexanoic acid 
are dissolved in 50 mL of 1,2-dichlorobenzene. The reaction mixture is refluxed for 20 h. 
After cooling to room temperature, the solvent is decanted and the brown amorphous residue 
is triturated with few 2-propanol until it crystallizes. The white crystals are sucked off, 
washed with ether and dried in a desiccator over P2O5 [6]. 
 
Yield: 5.62 g (16.6 mmol, 47%), white powder, C16H20BrNO2 (338.24 g/mol). 
m.p.: 135-137 °C. Rf (silica gel RP-18, methanol): 0.58. 
1H-NMR (d6-DMSO, TMS external): δ 9.40 (d, 1H), 8.60-8.50 (m, 2H), 8.25 (t, 1H), 8.05 (d, 
2H), 4.95 (t, 2H), 2.45 (s, 3H), 2.20 (t, 2H), 1.95 (m, 2H), 1.55 (m, 2H), 1.40 (m, 2H). 
 
4.2.8.2. 6-[4-(2-Butoxy-3,4-dioxo-cyclobut-1-enylmethylene)-4H-quinolin-1-yl]-hexanoic 
Acid 
118 mg (0.35 mmol) of 6-(4-methyl-1-quinolinium)hexanoic acid bromide and 87.5 µL (0.40 
mmol) of squaric acid dibutylester are dissolved in 5 mL of ethanol. 250 µL of triethylamine 
are added and the mixture is refluxed for 20 min. The solvent is removed on a rotary 
evaporator. The raw product is purified by column chromatography using silica gel 60 as the 
stationary phase and a chloroform/methanol mixture (90:10 v/v) as the eluent. 
 
Yield: 41.0 mg (0.10 mmol, 29%), amorphous red product, C24H27NO5 (409.48 g/mol). 
Rf (silica gel, chloroform:methanol 90:10 v/v): 0.49. 
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1H-NMR (CDCl3, TMS): δ 8.13 (d, 1H), 7.92 (d, 1H), 7.60-7.53 (m, 1H), 7.35-7.29 (m, 2H), 
7.14 (d, 1H), 6.04 (s, 1H), 4.81 (t, 2H), 4.03 (t, 2H), 2.37 (t, 2H), 1.81 (m, 4H), 1.69 (m, 2H), 
1.49 (m, 4H), 0.99(t, 3H). 
 
4.2.8.3. FR661-Butylester 
300 mg (0.68 mmol) of 1-(5-carboxypentyl)-4-(1-(2-butoxy-3,4-dioxo-1-cyclobutenyl) 
methylidene)-1,4-dihydroquinoline and 300 mg (0.74 mmol) of 1-[2-(diethoxyphosphoryl) 
ethyl]-2,3,3-trimethyl-3H-indolium bromide are dissolved in 60 mL of a 1-butanol/toluene 
mixture (1:1 v/v) and heated under reflux for 48 h. After cooling to room temperature the 
solvent is removed under reduced pressure. The raw product is purified by column 
chromatography using silica gel 60 as the stationary phase and a chloroform/methanol 
mixture (90:10 v/v) as the eluent. 
 
Yield: 33.2 mg (45.5 µmol, 7%), amorphous green product, C41H51N2O7P (714.84 g/mol). 
Rf (silica gel, chloroform:methanol 90:10 v/v): 0.62. 
1H-NMR (d4-methanol, TMS): δ 9.01 (d, 1H), 8.47 (d, 1H), 8.25 (d, 1H), 7.93 (m, 2H), 7.69 
(t, 1H), 7.29 (m, 2H), 7.03 (m, 2H), 6.68 (s, 1H), 5.64 (s, 1H), 4.57 (t, 2H), 4.22-4.01 (m, 8H), 
2.34 (t, 2H), 2.14-1.93 (m, 2H), 1.71-1.10 (m, 16H), 0.91 (t, 9H). 
ESI-MS: m/e (M+H+, cation) for C41H52N2O7P, calculated 715.4, found 715.4. 
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4.2.8.3. FR661-Acid 
 
12 mg (16.4 µmol) of FR661-butylester are dissolved in 2 mL of a methanol/water mixture 
(1:1 v/v). A saturated solution of Na2CO3 in a methanol/water mixture (1:1 v/v) is added and 
the solution is stirred for 20 h at room temperature. The solvent is removed on a rotary 
evaporator. The raw product is purified by column chromatography using silica gel as the 
stationary phase and a chloroform/methanol mixture (60:40 v/v) as the eluent. 
 
Yield: 8.0 mg (12.1 µmol, 74%), green powder, C37H43N2O7P (658.73 g/mol). 
Rf (silica gel, chloroform:methanol 90:10 v/v): 0.39. 
ESI-MS: m/e (M-H+, anion) for C37H42N2O7P, calculated 657.3, found 657.1. 
 
4.2.8.4. FR661-OSI Ester 
N(CH2)5BuOOC CH
O
CH
O
N
(CH2)2
PO(OEt)2Na2CO3
methanol/water
N(CH2)5HOOC CH
O
CH
O
N
(CH2)2
PO(OEt)2
C41H51N2O7P
714.84
C37H43N2O7P
658.73
N(CH2)5HOOC CH
O
CH
O
N
(CH2)2
PO(OEt)2NHS/DCC
acetonitrile/DMF
N(CH2)5OC CH
O
CH
O
N
(CH2)2
PO(OEt)2
ON
O
O
C37H43N2O7P
658.73
C41H46N3O9P
755.80
4. Experimental Part  100 
3.5 mg (5.3 µmol) of FR661-acid, 1.2 mg (10.6 µmol) of NHS, and 2.2 mg (10.6 µmol) of 
DCC are dissolved in 1 mL of an acetonitrile/DMF mixture (1:1 v/v). The solution is stirred at 
room temperature for 18 h. The solvent is removed on a rotary evaporator and the raw product 
is washed several times with diethylether. 
 
Yield: 2.8 mg (3.7 µmol, 70%), green powder, C41H46N3O9P (755.80 g/mol). 
Rf (silica gel, chloroform:methanol 90:10 v/v): 0.51. 
 
4.2.9. FR662 
4.2.9.1. 2-(2,3-Dibutoxy-4-oxo-2-cyclobutenyliden)malonodinitrile  
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2.16 mL (10 mmol) of squaric acid dibutylester are dissolved in 40 mL of anhydrous THF. 
660 mg (10 mmol) of malonodinitrile are added under stirring. Then, a solution of 1.65 mL 
(12 mmol) of triethylamine in 3 mL of THF is added slowly via a dropping funnel. The 
solution is stirred at room temperature for 15 h. Then, 50 mL of dichloromethane and 100 mL 
of water are added. The product is extracted into the organic phase and separated. The 
aqueous phase is extracted twice with 20 mL of dichloromethane each. The organic phases are 
unified and dried over Na2SO4. The solvent is removed under vacuum and a yellow oil 
remains which is washed several times with diethylether [7, 8]. 
 
Yield: 1.7 g (63%), yellow oil, C15H18N2O3 (274.31 g/mol). 
Rf (RP-18, methanol:water 2:1 v/v): 0.90. 
CHN: calcd. C 65.68%, H 6.61%, N 10.21% found C 65.35%, H 6.51%, N 10.11%. 
UV: λ (methanol) = 333 nm, 204 nm, IR: 2205 cm-1 (C≡N). 
EI-MS: m/e (M+, cation) for C15H18N2O3, calcd. 274.3, found 274.3. 
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4.2.9.2. {2-[2-(2-Butoxy-4-dicyanomethylene-3-oxo-cyclobut-1-enylmethylene)-3,3-
dimethyl-2,3-dihydro-indol-1-yl]-ethyl}-phosphonic acid monoetyl ester 
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3.00 g (7.42 mmol) of 1-[2-(diethoxyphosphoryl)ethyl]-2,3,3-trimethyl-3H-indolium bromide 
and 2.00 mg (7.29 mmol) of 2-(2,3-dibutoxy-4-oxo-2-cyclobutenyliden)malonodinitrile are 
dissolved in 30 mL of ethanol. 1 mL of triethylamine is added and the solution is refluxed for 
12 h. After cooling to room temperature the solvent is removed on a rotary evaporator. The 
brown residue is dissolved in 100 mL of water and extracted seven times with 30 mL of ether. 
The aqueous phase is collected and water is removed on a rotary evaporator. The raw 
intermediate is purified by column chromatography using silica gel 60 RP-18 (40-63 µm) as 
the stationary phase and a methanol/water mixture (50:50 v/v) as the eluent. The first orange 
fraction is collected and the solvent is removed on a rotary evaporator.  
Yield: 1.95 g (53%), orange oil, C26H30N3O5P (495.52 g/mol).  
 
4.2.9.3. FR662-Butylester 
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1.00 g (2.83 mmol) of 1-(5-carboxypentyl)-2,3,3-trimethyl-3H-5-indoliumsulfonate and 1.48 
g (2.83 mmol) of {2-[2-(2-Butoxy-4-dicyanomethylene-3-oxo-cyclobut-1-enylmethylene)-
3,3-dimethyl-2,3-dihydro-indol-1-yl]-ethyl}-phosphonic acid monoethyl ester are refluxed in 
80 ml of a 1-butanol/toluene mixture (1:1 v/v) for 18 h. After cooling to room temperature the 
solvents are removed in vacuum. The raw product is purified by column chromatography 
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using silica gel 60 RP-18 (40-63 µm) as the stationary phase and a methanol/water mixture 
(50:50 v/v) as the eluent.  
 
Yield: 290 mg (0.35 mmol, 12%), green crystals, C43H52N4O9PS (831.94 g/mol). 
Rf (silica gel RP-18, methanol:water 1:1 v/v): 0.13. 
1H-NMR (d4-methanol, TMS): δ 7.87 (m, 2H), 7.54 (d, 1H), 7.49 (d, 1H), 7.41 (dt, 1H), 7.27 
(m, 2H), 6.47 (s, 1H), 6.42 (s, 1H), 4.35 (m, 2H), 4.06 (m, 4H), 3.87 (quin, 2H), 2.33 (t, 2H), 
2.08 (dt, 2H), 1.81 (m, 2H), 1.77 (s, 6H), 1.76 (s, 6H), 1.69 (t, 2H), 1.59 (m, 2H), 1.49 (m, 
2H), 1.36 (m, 2H), 1.11 (t, 3H), 0.93 (t, 3H). 
ESI-MS: m/e (M-H+, anion) for C43H51N4O9PS, calculated 830.3, found 829.3. 
 
4.2.9.4. FR662-Acid 
 
N
O
C
CH
CNNC
(CH2)2
PO(OH)(OEt)
CH
N
(CH2)5
COOBu
SO3H
C43H52N4O9PS
831.94
N
O
C
CH
CNNC
(CH2)2
PO(OH)(OEt)
CH
N
(CH2)5
COOH
SO3H
C39H44N4O9PS
775.83
HCl
 
290 mg (0.35 mmol) of FR662-butylester are dissolved in 9 mL of water. 1 mL of 1N HCl is 
added and the mixture is refluxed for 2 h. The solvent is decanted and the raw product is 
purified by column chromatography using silica gel 60 RP-18 (40-63 µm) as the stationary 
phase and a methanol/water mixture (50:50 v/v) as the eluent.  
 
Yield: 155 mg (0.20 mmol, 57%), green crystals, C39H44N4O9PS (775.83 g/mol). 
Rf (silica gel RP-18, methanol:water 1:1 v/v): 0.51. 
1H-NMR (d4-methanol, TMS): δ 7.89 (m, 2H), 7.49 (d, 1H), 7.43-7.32 (m, 3H), 7.27 (t, 1H),  
6.48 (s, 1H), 6.46 (s, 1H), 4.40 (m, 2H), 4.09 (m, 2H), 3.97 (quin, 2H), 2.30 (m, 4H), 1.83 (t, 
2H), 1.78 (s, 6H), 1.76 (s, 6H), 1.68 (m, 2H), 1.51 (m, 2H), 1.16 (t, 3H). 
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4.2.9.5. FR662-OSI Ester 
 
N
O
C
CH
CNNC
(CH2)2
PO(OH)(OEt)
CH
N
(CH2)5
COOH
SO3H
C39H44N4O9PS
775.83
N
O
C
CH
CNNC
(CH2)2
PO(OH)(OEt)
CH
N
(CH2)5
CO
SO3H
O
N OOC43H47N5O11PS
872.91
NHS/DCC
DMF
 
 
50.0 mg (64.4 µmol) of FR662-acid, 19.9 mg (96.6 µmol) of DCC and 11.1 mg (96.6 µmol) 
of NHS are dissolved in 1 mL of dry DMF. The solution is stirred for 20 h at room 
temperature. The reaction mixture is filtered and the solvent is removed in vacuum. The 
product is purified by column chromatography using silica gel 60 RP-18 (40-63 µm) as the 
stationary phase and a methanol/water mixture (80:20 v/v) as the eluent.  
 
Yield: 26 mg (46%), green crystals, C43H47N5O11PS (872.91 g/mol). 
1H-NMR (d4-methanol, TMS): δ 7.87 (m, 2H), 7.50 (m, 2H), 7.39 (m, 1H), 7.27 (m, 1H), 6.46 
(s, 1H), 6.42 (s, 1H), 4.38 (m, 2H), 4.06 (m, 2H), 3.87 (quin, 2H), 2.67 (s, 4H), 2.30 (t, 2H), 
2.09 (dt, 2H), 1.82 (m, 2H), 1.77 (s, 6H), 1.76 (s, 6H), 1.68 (m, 2H), 1.51 (m, 2H), 1.11 (t, 
3H). 
 
4.2.10. FR670 
4.2.10.1. FR670-Acid 
O
BuO
C(CN)2
OBu
N
C2H5
O3S
Br
C15H18N2O3
274.32
C13H17NO3S
267.34
(CH2)3
N
COOEt
C17H24BrNO2
354.29
(a) ethanol/triethylamine/
(b) 1-butanol/toluene 
(CH2)3
COOH
N
CH
C2H5
O3S
CH
OH
C(CN)2
N
C35H35N4O6S
639.75
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1.38 g (4.98 mmol) of 2-(2,3-dibutoxy-4-oxo-2-cyclobutenyliden)malonodinitrile and 1.33 g 
(4.98 mmol) of 1-ethyl-2,3,3-trimethyl-3H-5-indoliumsulfonate are dissolved in 60 mL of 
ethanol. 6 mL of triethylamine are added and the solution is refluxed for 6 h. After cooling to 
room temperature the solvent is removed on a rotary evaporator and an orange oil remains. 
The oil is dissolved in 75 mL of a 1-butanol/toluene mixture (2:1, v/v) and 1.76 g (4.98 
mmol) of 1-(3-ethoxycarbonyl-propyl)-2,3,3-trimethyl-3H-indolium bromide are added. The 
solution is heated to 110 °C for 20 h. After cooling to room temperature the solvent is 
removed on a rotary evaporator. The dark green residue is dissolved in 40 mL of ethanol. 10 
mL of ethanol, saturated with NaOH, are added and the green solution is heated to 50 °C, 
whereupon the color turns brown. After cooling to room temperature, HCl (35%) is added 
dropwise until neutral pH is reached. The solvent of the green solution is removed. The 
residue is suspended in an ethanol/acetone mixture (1:1, v/v). Unsoluble NaCl is sucked off. 
The solvent of the solution containing the raw product is removed, and the product is purified 
by column chromatography using silica gel 60 RP-18 (40-63 µm) as the stationary phase and 
a methanol/water mixture (40:60 v/v) as the eluent. 
 
Yield: 171 mg (268 µmol, 5%), golden-green powder, C35H34N4O6S (638.74 g/mol). 
Rf (silica gel RP-18, methanol:water 8:2 v/v): 0.69. 
1H-NMR (d4-methanol): δ 7.85 (m, 2H), 7.50 (m, 2H), 7.40 (dt, 1H), 7.28 (m, 1H), 6.46 (s, 
1H), 6.40 (s, 1H), 4.18 (t, 2H), 4.10 (q, 2H), 2.34 (t, 2H), 2.07 (m, 2H), 1.37 (t, 3H). 
 
4.2.10.2. FR670-OSI Ester 
 
(CH2)3
COOH
N
CH
C2H5
O3S
CH
OH
C(CN)2
N
C35H35N4O6S
639.75
(CH2)3
N
CH
C2H5
O3S
CH
OH
C(CN)2
N
CO
O
N OO
NHS/DCC/
acetonitrile
C39H37N5O8S
735.81
 
 
4.0 mg (6.25 µmol) of FR670-acid, 1.4 mg (12.5 µmol) of NHS, and 2.6 mg (12.3 µmol) of 
DCC are dissolved in 1 mL of acetonitrile. The solution is stirred at room temperature for 20 
h. After filtration the solvent is removed on a rotary evaporator. 
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Yield: 3.1 mg (4.31 µmol, 69%), green powder, C39H37N5O8S (735.81 g/mol). 
Rf (silica gel RP-18, methanol:water 8:2 v/v): 0.55. 
 
4.2.11. OB630 
4.2.11.1 1-(6-Hydroxyhexyl)-2,3,3-trimethyl-3H-indolium Bromide 
 
N
C11H13N
159.23
N
(CH2)6
OH
Br
C17H26BrNO
340.30
6-bromo-1-hexanol
acetonitrile
 
 
700 µL (4.35 mmol) of 2,3,3-trimethyl-3H-indole and 856 µL (6.53 mmol) of 6-bromo-1-
hexanol are dissolved in 9 mL of acetonitrile and refluxed for 20 h. After cooling to room 
temperature the solvent is removed on a rotary evaporator. The raw product is dissolved in 
water and extracted with ether. The aqueous phase is collected and water is removed on a 
rotary evaporator. The product is dried in a desiccator over P2O5. 
 
Yield: 605 mg (1.78 mmol, 41%), faintly violett powder, C17H26BrNO (340.30 g/mol). 
Rf (silica gel RP-18, methanol): 0.61. 
1H-NMR (methanol, TMS): δ 7.87 (m, 1H), 7.77 (m, 1H), 7.67 (m, 2H), 4.51 (t, 2H), 3.56 (t, 
2H), 1.97 (m, 2H), 1.61 (s, 6H), 1.50 (m, 6H). 
 
4.2.11.2. 3-Butoxy-4-(1,3,3-trimethyl-1,3-dihydro-indol-2-ylidenemethyl)-cyclobut-3-
ene-1,2-dione 
 
N
C12H15N
173.26
OO
OBuBuO
C12H18O4
226.27
N
CH
O
O
OBu
triethylamine
ethanol
C20H23NO3
325.41
+
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2.16 mL (10.0 mmol) of 3,4-dibutoxy-3-cyclobutene-1,2-dione and 2 mL of triethylamine are 
dissolved in 15 mL of ethanol and heated to 70 °C. 2.66 mL (15.7 mmol) of 2-methylene-
1,3,3-trimethylindoline are added, and the reaction mixture is refluxed for one hour. After 
cooling to room temperature the solvents are removed on a rotary evaporator, and a brown 
liquid remains. The residue is triturated with 15 mL of diethylether and is allowd to stand 1-2 
hours at 4 °C whereupon the liquid crystallizes in yellow needles. Diethylether is decanted 
and the crystalls are washed with small amounts of cold ether and dried in a desiccator over 
P2O5. 
 
Yield: 1.57 g (4.82 mmol, 48%), yellow crystalls, C20H23NO3 (325.41 g/mol). 
Rf (silica gel, chloroform: methanol 97:3 v/v): 0.87. 
 
4.2.11.3. 3-Hydroxy-4-(1,3,3-trimethyl-1,3-dihydro-indol-2-ylidenemethyl)-cyclobut-3-
ene-1,2-dione 
 
N
CH
O
O
OBu
C20H23NO3
325.41
N
CH
O
O
OH
C16H15NO3
269.30
NaOH
ethanol
 
 
1.57 g (4.82 mmol) of 3-butoxy-4-(1,3,3-trimethyl-1,3-dihydro-indol-2-ylidenemethyl)-
cyclobut-3-ene-1,2-dione are suspended in 10 mL of ethanol and heated to 70 °C. 500 µL of a 
50% (w/w) NaOH solution in water are added whereupon the reaction mixture turns to a 
brown solution which is refluxed for 10 min. After cooling yellow crystalls precipitate. 7 mL 
of 2 N HCl are added and the product is sucked off. 
 
Yield: 1.10 g (4.08 mmol, 85%), yellow crystalls, C16H15NO3 (269.30 g/mol). 
Rf (silica gel, chloroform: methanol 97:3 v/v): 0.78. 
1H-NMR (d1-chloroform/TMS): δ 7.28 (m, 2H), 7.07 (t, 1H), 6.89 (d, 1H), 5.36 (s, 1H), 3.39 
(s, 3H), 1.62 (s, 6H). 
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4.2.11.4. OB630-OH 
 
N
CH
O
O
OH
N
(CH2)6
OH
Br
C17H26BrNO
340.30
N
CH
O
CH
O
N
(CH2)6
OH
C16H15NO3
269.30
C33H38N2O3
510.68
+
butanol/
toluol
 
 
310 mg (1.15 mmol) of 3-hydroxy-4-(1,3,3-trimethyl-1,3-dihydro-indol-2-ylidenemethyl)-
cyclobut-3-ene-1,2-dione and 391 mg (1.15 mmol) of 1-(6-hydroxyhexyl)-2,3,3-trimethyl-3H-
indolium bromide are dissolved in 30 mL of a butanol/toluene mixture (1/1, v/v) and refluxed 
for 24 h. After cooling the solvents are removed on a rotary evaporator and the product is 
purified by chromatography using silica gel 60 (40-63 µm) as the stationary phase and a 
chloroform/methanol mixture (97/3, v/v) as the eluent. The second blue fraction is collected 
which contains the unsymmetrical dye. 
 
Yield: 138 mg (0.27 mmol, 23%), blue crystalls, C33H38N2O3 (510.68 g/mol). 
Rf (silica gel, chloroform: methanol 9:1 v/v): 0.54. 
Rf (silica gel RP 18, chloroform: methanol 95:5 v/v): 0.51. 
1H-NMR (d1-chloroform, TMS): δ 7.37 (m, 4H), 7.21 (m, 2H), 7.06 (d, 2H),  6.41 (s, 1H), 
6.22 (s, 1H), 4.13 (t, 2H), 4.09 (m, 2H), 3.69 (t, 2H), 3.65 (s, 3H), 1.86 (m, 2H), 1.76 (s, 6H), 
1.74 (s, 6H), 1.62 (m, 2H), 1.56 (m, 2H), 1.37 (m, 2H). 
 
4.2.11.5. OB630-PAM 
 
N
CH
O
CH
O
N
(CH2)6
OH
C33H38N2O3
510.68
N
CH
O
CH
O
N
(CH2)6
O
PO
N
(CH2)2NC
P
NN
O
(CH)2
CN
C42H55N4O4P
710.90
+ tetrazoledichloromethane
C15H32N3OP
301.41  
 
50 mg (97.9 µmol) of OB630-OH are dissolved in 3 mL of dry dichloromethane under argon. 
47.5 µL (166 µmol) of 2-cyanoethyl-N,N,N',N',-tetraisopropyl-phosphordiamidite and 330 µL 
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of a saturated tetrazole solution in acetonitrile are added under stirring. The solution is stirred 
for 1 h at room temperature, and then extracted twice with 5 mL of a 5% NaHCO3 solution in 
water and once with 10 mL of a saturated aqueous NaCl solution. The organic phase is dried 
over Na2SO4. The product is purified by two successive column chromatographies using 
LiChroprep RP-18 (40-63 µm) as the stationary phase and first dichloromethane as the eluent 
and second an acetonitrile/dichloromethane mixture (95:5 v/v) as the eluent. 
  
Yield: 30 mg (42.2 mmol, 43%), blue crystalls, C43H55N4O4P (710.90 g/mol). 
Rf (silica gel RP 18, chloroform:methanol 95:5 v/v): 0.57. 
1H-NMR (d6-acetone): δ 7.48 (m, 2H), 7.33 (m, 2H), 7.28 (m, 2H), 7.17 (m, 2H), 5.94 (s, 1H), 
5.86 (s, 1H), 4.16 (t, 2H), 3.85 (m, 2H), 3.70-3.58 (m, 7H), 2.74 (t, 2H), 1.87 (m, 2H), 1.77 (s, 
6H), 1.76 (s, 6H), 1.63 (m, 2H), 1.52 (m, 4H), 1.16 (dd, 12H). 31P{1H}-NMR (d6-acetone, 
H3PO4 external): δ 148.56. 
 
4.2.12. OG670 
4.2.12.1. 2-[3-Butoxy-4-oxo-2-(1,3,3-trimethyl-1,3-dihydro-indol-2-ylidenemethyl)-
cyclobut-2-enyl]malonodinitrile 
 
N
C12H15N
173.26
C(CN)2O
OBuBuO
N
CH
C(CN)2
O
OBu
triethylamine
ethanol+
C15H18N2O3
274.32
C23H23N3O2
373.45
 
2.11 g (7.68 mmol) of 2-(2,3-dibutoxy-4-oxo-2-cyclobutenyliden)malonodinitrile and 6.79 
mL of triethylamine are dissolved in 100 mL of ethanol and heated to 60 °C. 1.36 mL (7.68 
mmol) of 2-methylene-1,3,3-trimethylindoline are added and the reaction mixture is kept at 
60 °C for 6 h. After cooling to room temperature the solvents are removed on a rotary 
evaporator and a brown oil remains. The raw product can be used without further purification. 
4. Experimental Part  109 
4.2.12.2. OG670-OH 
 
N
CH
C(CN)2
O
OBu
N
(CH2)6
OH
Br
C17H26BrNO
340.30
N
CH
C(CN)2
CH
O
N
(CH2)6
OH
+
butanol/
toluol
C23H23N3O2
373.45
C36H38N4O2
558.72  
 
3.29 g of raw 2-[3-butoxy-4-oxo-2-(1,3,3-trimethyl-1,3-dihydro-indol-2-ylidenemethyl)-
cyclobut-2-enyl]malonodinitrile and 1.80 g (5.29 mmol) of 1-(6-hydroxyhexyl)-2,3,3-
trimethyl-3H-indolium bromide are dissolved in 200 mL of a butanol/toluene mixture (1/1, 
v/v) and refluxed for 24 h. After cooling to room temperature the solvents are removed on a 
rotary evaporator and the product is purified by chromatography using silica gel 60 (40-63 
µm) as the stationary phase and a chloroform/methanol mixture (95/5, v/v) as the eluent. The 
second green fraction is collected which contains the unsymmetrical dye. 
 
Yield: 532 mg (0.95 mmol, 18%), green crystalls, C36H38N4O2 (558.72 g/mol). 
Rf (silica gel RP 18, acetonitrile: chloroform 95:5 v/v): 0.38. 
 
4.2.12.3. OG670-PAM 
 
N
CH
C(CN)2
CH
O
N
(CH2)6
OH
N
CH
C(CN)2
CH
O
N
(CH2)6
O
PO
N
(CH2)2NC
P
NN
O
(CH)2
CN
+ tetrazoledichloromethane
C15H32N3OP
301.41
C36H38N4O2
558.72
C45H55N6O3P
758.94
 
150 mg (268 µmol) of OG670-OH are dissolved in 10 mL of dry dichloromethane under 
argon. 225 µL (795 µmol) of 2-cyanoethyl-N,N,N',N',-tetraisopropyl-phosphordiamidite and 
750 µL of a saturated tetrazole solution in acetonitrile are added under stirring. The solution is 
stirred for 1 h at room temperature, and then extracted twice with 10 mL of a 5% NaHCO3 
solution in water and once with 20 mL of a saturated aqueous NaCl solution. The organic 
phase is dried with Na2SO4. The product is purified by two successive column 
chromatographies using LiChroprep RP-18 (40-63 µm) as the stationary phase and first 
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dichloromethane as the eluent, second an acetonitrile/dichloromethane mixture (95:5 v/v) as 
the eluent. 
  
Yield: 105 mg (138 mmol, 52%), green crystalls, C45H55N6O3P (758.94 g/mol). 
Rf (silica gel RP 18, acetonitrile: chloroform 95:5 v/v): 0.46. 
1H-NMR (d6-acetone): δ 7.54 (m, 2H), 7.40 (m, 4H), 7.26 (m, 2H), 6.52 (s, 1H), 6.48 (s, 1H), 
4.12 (t, 2H), 3.83 (m, 2H), 3.68 (s, 3H), 3.67-3.58 (m, 4H), 2.72 (t, 2H), 1.88 (m, 2H), 1.78 (s, 
6H), 1.76 (s, 6H), 1.62 (m, 2H), 1.50 (m, 4H), 1.17 (dd, 12H). 31P{1H}-NMR (d6-acetone, 
H3PO4 external): δ 148.65. 
 
4.3. General Labeling Procedures 
4.3.1. General Procedure for Labeling Proteins and Determination of Dye-to-
 Protein Ratios 
Protein labeling was carried out in a 50 mM bicarbonate buffer (BCBS) of pH 9.0. 2 mg of 
protein (HSA or anti-HSA) are dissolved in 1 mL of BCBS. Different amounts of OSI ester 
(0.01-0.25 mg) are added to give different dye-to-protein ratios (DPR = 0.4-7). The mixtures 
are gently stirred for 1 h at room temperature in the dark. Unconjugated label is separated 
from the labeled proteins using gel permeation chromatography with Sephadex G-25 and a 22 
mM phosphate buffer of pH 7.2 as the eluent. The first colored band containes the dye-protein 
conjugate, while the colored band with a much longer retention time containes the separated 
free dye [9-11]. 
 The dye-to-protein ratio (DPR) can be determined with the help of the following 
formula, which is derived from the Lambert-Beer law: 
              Amax . εP280 nm
A280 nm . εFmax - Amax . εF280 nm
=DP
 
with εP280 nm = molar absorption coefficient of the protein at 280 nm, 
 εF280 nm = molar absorption coefficient of the dye at 280 nm, 
 εFmax = molar absorption coefficient of the free dye at its maximum, 
 Amax  = absorbance of the dye-protein solution at its maximum, 
 A280 nm  = absorbance of the dye-protein solution at 280 nm. 
This formula is valid assuming that at long-wavelengths only the label absorbs and that there 
are no spectral differences between the free and the covalently bound dye. 
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4.3.2. General Procedure for Labeling Amino Acids  
30 mmol of amino acid (L-valine or L-aspartic acid) are dissolved in 500 µL of BCBS (50 
mM, pH 9.0). A solution of 10 mmol of dye OSI ester in 50 µL of DMF is added. The 
solution is stirred at room temperature for 30 h. The conjugate is purified by HPLC using a 
Hibar pre-packed column RT (250 x 4 mm) packed with LiChrosorb RP 18 (10 µm) as the 
stationary phase and a methanol/water mixture (50:50, v/v) as the eluent. 
FO546-valine: 1H-NMR (d4-methanol): δ 8.54 (t, 1H), 7.53 (m, 2H), 7.47-7.27 (m, 6H), 6.48 
(dd, 2H), 4.30 (m, 2H), 4.22 (d, 1H), 4.17 (t, 2H), 3.96 (quin, 2H), 2.23 (m, 2H), 2.11 (m, 
1H), 2.01 (m, 2H), 1.84 (m, 2H), 1.76 (s, 12H), 1.60 (m, 2H), 1.47-1.32 (m, 6H), 1.26 (t, 3H), 
0.87 (dd, 6H). 
FO546-aspartic acid: 1H-NMR (d4-methanol): δ 8.54 (t, 1H), 7.53 (m, 2H), 7.47-7.27 (m, 
6H), 6.48 (dd, 2H), 4.48 (t, 1H), 4.30 (m, 2H), 4.17 (t, 2H), 3.96 (quin, 2H), 2.65 (d, 1H), 2.20 
(t, 2H), 2.01 (m, 2H), 1.83 (m, 2H), 1.76 (s, 12H), 1.60 (m, 2H), 1.47-1.37 (m, 6H), 1.26 (t, 
3H). 
FR642-valine: 1H-NMR (d4-methanol): δ 8.23 (dt, 2H), 7.47 (t, 2H), 7.42-7.22 (m, 6H), 6.64 
(t, 1H), 6.32 (dd, 2H), 4.25 (m, 2H), 4.22 (d, 1H), 4.13 (t, 2H), 3.97 (quin, 2H), 2.27 (t, 2H), 
2.13 (m, 1H), 1.98 (m, 2H), 1.84 (t, 2H), 1.72 (s, 6H), 1.71 (s, 6H), 1.64 (m, 2H), 1.47 (m, 
2H), 1.28 (t, 3H), 0.97 (dd, 6H). 
FR642-aspartic acid: 1H-NMR (d4-methanol): δ 8.22 (m, 2H), 7.49-7.21 (m, 8H), 6.64 (t, 
1H), 6.31 (dd, 2H), 4.50 (m, 1H), 4.24 (m, 2H), 4.13 (t, 2H), 3.97 (quin, 2H), 2.66 (t, 2H), 
2.24 (t, 2H), 1.98 (m, 2H), 1.81 (m, 2H), 1.72 (s, 6H), 1.71 (s, 6H), 1.49 (m, 2H), 0.32 (m, 
2H), 1.28 (t, 3H). 
 
4.3.3. General Procedure for Labeling Oligonucleotides 
0.30 µmol of amino modified 15-mer oligonucleotide are dissolved in 500 µL of BCBS (50 
mM, pH 9.0). 2 mg of dye OSI ester dissolved in 50 µL of DMF are added and the solution is 
allowed to stand for 15 h in the dark. 1.5 mL of ice-cold ethanol are added. The solution is 
mixed well and placed at -18 °C for 1-2 h. The solution is centrifuged at 15,000 RPM for 10 
min. The supernatant containing unreacted dye is removed carefully and the pellet containing 
labeled and unlabeled oligonucleotide is rinsed twice with cold ethanol. 
Labeled oligonucleotides are purified by HPLC using a Hibar pre-packed column RT 
(250 x 4 mm) packed with LiChrosorb RP 18 (10 µm). The pellet is dissolved in 0.1 M 
triethylammonium acetate (TEAA) of pH 7.1. The dissolved pellet is loaded onto the column 
in 0.1 M TEAA and a linear 10-65% acetonitrile gradient is run over 30 min. In all cases, the 
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unlabeled oligonucleotide migrates fastest, followed by the labeled oligonucleotide, and 
finally the free dye-acid, and the OSI ester [12]. The solvent of the HPLC fraction is removed 
on a rotary evaporator.  
 The residue is dissolved in 100 µL of water. 1 mL of ice-cold ethanol is added. The 
solution is mixed well and and placed at -18 °C for 1-2 h. The solution is centrifuged at 
15,000 RPM for 10 min. The supernatant is removed carefully and the pellet containing the 
labeled oligonucleotide can either be stored at 4 °C or be dissolved in 22 mM PBS for further 
experiments. 
 
4.3.3. General Procedure for Labeling dUTP 
 
O
OH
OPO
O
P
O
O
O
O
P
O
HO
O
N
N
O
O
NH2
H
DYE NHS
O
OH
OPO
O
P
O
O
O
O
P
O
HO
O
N
N
O
O
NH
H DYE
+
 
 
1 mg (1.91 µmol) of amino allyl dUTP is dissolved in 500 µL of BCBS (50 mM, pH 9.0). A 
solution of 2.9 µmol of dye OSI ester in 100 µL of DMF is added. The solution is stirred for 4 
h at room temperature. Labeled dUTP is separated from the non labeled dUTP and the non 
reacted dye using gel permeation chromatography with Sephadex G-10 as the stationare phase 
and doubly destilled water as the eluent. The first colored band which containes the conjugate 
is lyophilized. 
 The labeled dUTP was used in fluorescence in situ hybridization (FISH) studies. PCR 
and FISH was carried out by Chrombios GmbH (Martinsried, Germany). 
 
4.4. Determination of Quantum Yields [13] 
The quantum yields φ of the dyes and the dye conjugates, respectively, were measured in 
phosphate buffer (22 mM, pH 7.2) relative to a reference fluorophor with a known quantum 
yield. These references were Cy5 (Amersham) with a quantum yield of 0.28 in PBS [14] for 
dyes absorbing from 630 to 670 nm, and Rhodamine 6G (Aldrich) with a quantum yield of 
0.95 in ethanol [13] for dyes absorbing from 530 to 550 nm. The quantum yields φx of the 
dyes and the dye conjugates were determined using the following formula: 
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where φR is the quantum yield of the reference, AR and AX are the absorbances of the reference 
and the dye, respectively, at the excitation wavelength, IR and IX are the integrated areas of the 
corrected emission spectra of the reference and the dye, respectively, and nR and nX are the 
refractive indices of the solvent of the reference and the dye, respectively. 
 
4.5. Determination of Dissociation Constants KD* 
Dissociation constants KD* of non-reactive dyes and HSA were determined as follows. The 
values y1 and y2 were determined graphically as shown in figure 4.1. y3 was calculated 
according to the following formula: 
2
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The corresponding x value to y3 gives KD* which is the concentration of HSA needed to bind 
half of the non-reactive dye. 
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Figure 4.1. Plot of the fluorescence intensities the free dye at the emission maximum 
versus the concentration of added HSA. 
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4.6. General Procedures for Energy Transfer Measurements 
4.6.1. Immunostudies and Hybridization Studies 
Varying quantities (typically 25-400 µL) of acceptor solution of a certain concentration 
(typically 10-6-10-7 mol/L) were diluted with 22 mM PBS of pH 7.2 to a final volume of 400 
µL. 100 µL of donor solution with the same concentration were added. After incubation of 20 
min at room temperature fluorescence was measured at 20 °C. 
 
4.6.2. Competitive Assays 
Varying quantities (typically 25-400 µL) of a solution of the non labeled probe (protein 
or oligonucleotide) were diluted with 22 mM PBS of pH 7.2 to a final volume of 400 µL. 
Then, 100 µL of donor solution and 100 µL of acceptor solution were added in this 
order. All three solutions had the same concentration (typically 10-6-10-7 mol/L). After 
incubation of 20 min at room temperature fluorescence was measured at 20 °C. 
 
4.7. Flow-Cytometry 
For flow-cytometric measurements "Development COOH Microspheres" of 5.6 µm diameter 
(1.25·107 beads/mL) from Luminex (Austin, Texas) were used. The following solutions were 
needed: activation buffer (AB), 0.1 M PBS, pH 6.1; sulfo-NHS solution, 10 mg sulfo-NHS in 
200 mL of AB; EDC solution, 5 mg EDC in 1 mL of AB; coupling buffer (CB), 25 mM PBS, 
150 mM NaCl, pH 7.3; washing buffer (WB), 10 mL CB + 5 µL Tween 20; blocking buffer 
(BB), 0.1 M TRIS-HCl, pH 7.3. 
 The microsphere stock was dispersed with sonification and vortexed for 1 min. 40 µL 
of the stock were taken and centrifuged for 2 min at 13,000 rpm. The supernatant was 
aspirated and the pellet was resuspended in 40 µL of AB. The suspension was vortexed and 
centrifuged for 1 min at 13,000 rpm. Again the supernatant was aspirated and the pellet was 
resuspended in 16 µL of AB. 2 µL of freshly prepared sulfo-NHS solution and 2 µL of freshly 
prepared EDC solution were added. The suspension was mixed and allowed to stand for 20 
min in the dark at room temperature. 30 µL of AB were added. The suspension was mixed 
and centrifuged for 2 min at 13,000 rpm. The supernatant was aspirated and the pellet was 
resuspended in 50 µL of CB. Again, the suspension was centrifuged for 2 min at 13,000 rpm. 
The supernatant was aspirated and the pellet was resuspended in 50 µL of CB.  
 Six cups were prepared containing 5µL of the activated particles. 5 µL of different 
amounts of HSA dissolved in CB (0, 31, 63, 125, 250, and 500 µg/mL) were added to the 
particle suspensions, respectively. The 6 suspensions were mixed and allowed to stand for 60 
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min in the dark at room temperature. 40 µL of CB were added. The suspensions were mixed 
and centrifuged for 2 min at 13,000 rpm. The supernatant was aspirated and the pellets were 
resuspended in 50 µL of WB. Again, the suspensions were centrifuged for 2 min at 13,000 
rpm. The supernatant was aspirated and the pellets were resuspended in 50 µL of WB. After a 
second washing step the pellets were resuspended in 50 µL of BB and allowed to stand for 30 
min in the dark at room temperature. The particles were washed twice with 50 µL of WB and 
the pellets were dispersed in 50 µL of WB. 
 Each of the six cups was divided into four cups with 8 µL of microsphere suspension 
each. 8 µL of different amounts of FO548 labeled anti-HSA (DPR=2.1) dissolved in CB (0, 8, 
33, and 131 µg/mL) were added to the particle suspensions, respectively. The 24 suspensions 
were mixed and allowed to stand for 2 h in the dark at 37 °C. After two washing steps the 
microsphere suspensions were measured on a Luminex 100 Flow Cytometer at Multimetrix 
(Regensburg). 
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5. Summary 
The aim of this work was the synthesis and spectral and analytical characterization of new 
long-wavelength fluorescent labels which can be coupled to biomolecules and be used as 
markers in biological applications.  
 The dyes belong to either the class of the cyanine dyes or to the squaraines. They were 
characterized by their absorption and emission spectra, their molar absorbance and their 
fluorescence quantum yields. Having absorption maxima in the range of 545 nm to 668 nm 
and emission maxima between 562 nm and 687 nm, the markers cover the longwave part of 
the visible spectrum. The labels exhibit molar absorbances between 86,000 L/(mol·cm) and as 
high as 220,000 L/(mol·cm).  
 The labels contain either amine-reactive oxysuccinimidyl (OSI) esters or saccharide-
reactive phosphoramidite (PAM) moieties. All labels contain solely one reactive group to 
avoid crosslinking. Several biomolecules were labeled. These include amino acids (L-valine, 
L-aspartic acid), proteins (HSA, anti-HSA), nucleotides (dUTP), and synthetic 
oligonucleotises (with and without amino-modification). In general, the quantum yield of the 
free dye in aqueous solution is low compared to the quantum yield of the dye covalently 
attached to a biomolecule (except for amino acids). In the case of proteins, the extent of the 
increase is dependent on the dye-to-protein ratio (DPR). The highest quantum yields are 
achieved at DPR values between 1 and 2, because at higher DPRs the dyes undergo self-
quenching, and fluorescence quantum yields decrease. 
 Immunostudies were carried out on the system HSA/anti-HSA. Binding studies were 
performed as well as homogenous competitive immunoassays. These systems can be used for 
the determination of HSA concentrations in the range of 2·10-9 - 2.5·10-7 mol/L. A cytometric 
measurement was performed to show the applicability of the dyes in flow cytometry. The 
introduced systems can be used for the determination of HSA concentrations in the range of 
10 - 120 µg/mL (1.5·10-7 - 1.8·10-6 mol/L). 
 Fluorescently labeled DNA oligonucleotides were applied in hybridization binding 
studies and homogenous competitive hybridization assays. The binding studies enable the 
determination of donor-to-acceptor distances. The presented competitive assays show that it is 
possible to determine oligonucleotide concentrations in the range of 4·10-8 to 6·10-6 mol/L. In 
addition, these measurements enable the distinction of oligonucleotides without, with a single, 
or with a double mismatch in their sequence. Fluorescence in situ hybridization has been 
performed. It was possible to clearly visualize under a fluorescence microscope that the 
labeled probe hybridized to a mouse Y-chromosome. 
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6. Acronyms, Definitions, and Nomenclature of the Dyes 
 
6.1. Acronyms 
anti-HSA polyclonal anti-human serum albumin 
BCBS bicarbonate buffer solution 
DCC dicyclohexylcarbodiimide 
DMF dimethylformamide 
DMSO dimethylsulfoxide 
DPR dye-to–protein ratio 
EDC ethyl(dimethylaminopropyl)carbodiimide 
ESI electro-spray ionization 
FAB fast-atom bombardment 
FRET fluorescence resonanz energy transfer 
HSA human serum albumin 
m.p. melting point 
NHS N-hydroxysuccinimide 
OSI oxysuccinimidyl 
PAM phosphoramidite 
PBS phosphate buffered saline 
TEAA triethylammonium acetate 
TMS tetramethylsilane 
sulfo-NHS 3-sulfo-N-hydroxysuccinimide 
 
6.2. Definitions 
fluorophore part of the dye that causes fluorescence 
label reactive dye 
conjugate biomolecule with covalently attached dye 
 
6.3. Nomenclature of the Dyes 
FO544-acid: 2-[3[1-(3-carboxypropyl)-1,3-dihydro-3,3-dimethyl-2H-indol-2-
ylidene]trienyl]-1-[2-(ethoxyhydroxyphosphoryl)ethyl]-3,3-dimethyl-indole 
FO545-acid: 2-[3[1-(5-carboxypentyl)-1,3-dihydro-3,3-dimethyl-2H-indol-2-
ylidene]trienyl]-1-[2-(ethoxyhydroxyphosphoryl)ethyl]-3,3-dimethyl-indole 
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FO546-acid: 2-[3[1-(7-carboxyheptyl)-1,3-dihydro-3,3-dimethyl-2H-indol-2-
ylidene]trienyl]-1-[2-(ethoxyhydroxyphosphoryl)ethyl]-3,3-dimethyl-indole 
FO548-acid: 2-[3[1-(5-carboxypentyl)-5-hydroxysulfonyl-1,3-dihydro-3,3-dimethyl-2H-
indol-2-ylidene]trienyl]-1-[2-(ethoxyhydroxyphosphoryl)ethyl]-3,3-dimethyl-
indole 
FR626-acid: 2-{[1-(5-carboxypentyl)-3,3-dimethyl-2,3-dihydro-1H-2-indolyliden]methyl}-
4-{[1-ethyl-5-hydroxsulfonyl-3,3-dimethyl-3H-2-indoliumyl]methylidene}-3-
oxo-1-cyclobuten-1-olate 
FR642-acid: 2-[5[1-(5-carboxypentyl)-1,3-dihydro-3,3-dimethyl-2H-indol-2-ylidene]-1,3-
pentadienyl]-1-[2-(ethoxyhydroxyphosphoryl)ethyl]-3,3-dimethyl-indole 
FR646-acid: 2-[5[1-(5-carboxypentyl)-5-hydroxysulfonyl-1,3-dihydro-3,3-dimethyl-2H-
indol-2-ylidene]-1,3-pentadienyl]-1-[2-(ethoxyhydroxyphosphoryl)ethyl]-3,3-
dimethyl-indole 
FR661-acid: 2-{[1-(2-(diethoxyphosphoryl)ethyl)-3,3-dimethyl-2,3-dihydro-1H-2-
indolyliden]methyl}-4-{[1-(5-carboxypentyl)-1,4-dihydro-4-
quinolinyl]methylidene}-3-oxo-1-cyclobuten-1-olate. 
FR662-acid: 2-{[1-(5-Carboxypentyl)-5hydroxysulfonyl-3,3-dimethyl-2,3-dihydro-1H-2-
indolyliden]methyl}-4-{[1-[2-(ethoxyhydroxyphosphoryl)ethyl]-3,3-dimethyl-
3H-2-indoliumyl]methylidene}-3-dicyanomethylene-1-cyclobuten-1-olate 
FR670-acid: 2-{[1-(3-Carboxypropyl)-3,3-dimethyl-2,3-dihydro-1H-2-indolyliden]methyl}-
4-{[5-hydroxysulfonyl-1-ethyl-3,3-dimethyl-3H-2-indoliumyl]methylidene}-3-
dicyanomethylene-1-cyclobuten-1-olate 
OB630-OH: 2-{[1-(6-Hydroxyhexyl)-3,3-dimethyl-2,3-dihydro-1H-2-indolyliden]methyl}-
4-{[1-methyl-3,3-dimethyl-3H-2-indoliumyl]methylidene}-3-oxo-1-
cyclobuten-1-olate. 
OG670-OH: 2-{[1-(6-Hydroxyhexyl)-3,3-dimethyl-2,3-dihydro-1H-2-indolyliden]methyl}-
4-{[1-methyl-3,3-dimethyl-3H-2-indoliumyl]methylidene}-3-
dicyanomethylene-1-cyclobuten-1-olate 
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